<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.lilly.com/role/Acquisitions" xlink:href="lly-20180331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AcquisitionsNarrativeDetails" xlink:href="lly-20180331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AcquisitionsPolicies" xlink:href="lly-20180331.xsd#AcquisitionsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AcquisitionsPurchasedPriceDetails" xlink:href="lly-20180331.xsd#AcquisitionsPurchasedPriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AcquisitionsTables" xlink:href="lly-20180331.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AssetImpairmentRestructuringAndOtherSpecialCharges" xlink:href="lly-20180331.xsd#AssetImpairmentRestructuringAndOtherSpecialCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AssetImpairmentRestructuringAndOtherSpecialChargesDetails" xlink:href="lly-20180331.xsd#AssetImpairmentRestructuringAndOtherSpecialChargesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/AssetImpairmentRestructuringAndOtherSpecialChargesTables" xlink:href="lly-20180331.xsd#AssetImpairmentRestructuringAndOtherSpecialChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/BasisOfPresentationAndRevenue" xlink:href="lly-20180331.xsd#BasisOfPresentationAndRevenue" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/BasisOfPresentationAndRevenueBasisOfPresentationAndRevenueDetails" xlink:href="lly-20180331.xsd#BasisOfPresentationAndRevenueBasisOfPresentationAndRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/BasisOfPresentationAndRevenueBasisOfPresentationAndRevenueTables" xlink:href="lly-20180331.xsd#BasisOfPresentationAndRevenueBasisOfPresentationAndRevenueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/CollaborationsAndOtherArrangements" xlink:href="lly-20180331.xsd#CollaborationsAndOtherArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/CollaborationsAndOtherArrangementsDetails" xlink:href="lly-20180331.xsd#CollaborationsAndOtherArrangementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/CollaborationsAndOtherArrangementsTables" xlink:href="lly-20180331.xsd#CollaborationsAndOtherArrangementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ConsolidatedCondensedBalanceSheets" xlink:href="lly-20180331.xsd#ConsolidatedCondensedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:href="lly-20180331.xsd#ConsolidatedCondensedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:href="lly-20180331.xsd#ConsolidatedCondensedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncomeUnaudited" xlink:href="lly-20180331.xsd#ConsolidatedCondensedStatementsOfComprehensiveIncomeUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:href="lly-20180331.xsd#ConsolidatedCondensedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfOperationsUnaudited" xlink:href="lly-20180331.xsd#ConsolidatedCondensedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/Contingencies" xlink:href="lly-20180331.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ContingenciesDetails" xlink:href="lly-20180331.xsd#ContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/DocumentAndEntityInformation" xlink:href="lly-20180331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstruments" xlink:href="lly-20180331.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsContractualMaturitiesDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsContractualMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsEffectOfRiskManagementInstrumentsDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsEffectOfRiskManagementInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsPolicies" xlink:href="lly-20180331.xsd#FinancialInstrumentsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsRealizedGainAndLossesDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsRealizedGainAndLossesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsRiskManagementInstrumentsDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsRiskManagementInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsTables" xlink:href="lly-20180331.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/FinancialInstrumentsUnrealizedGainAndLossesDetails" xlink:href="lly-20180331.xsd#FinancialInstrumentsUnrealizedGainAndLossesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ImplementationOfNewAccountingPronouncementsTables" xlink:href="lly-20180331.xsd#ImplementationOfNewAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ImplementationOfNewFinancialAccountingPronouncements" xlink:href="lly-20180331.xsd#ImplementationOfNewFinancialAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ImplementationOfNewFinancialAccountingPronouncementsDetails" xlink:href="lly-20180331.xsd#ImplementationOfNewFinancialAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/IncomeTaxes" xlink:href="lly-20180331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/IncomeTaxesDetails" xlink:href="lly-20180331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherComprehensiveIncomeLoss" xlink:href="lly-20180331.xsd#OtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherComprehensiveIncomeLossAociDetails" xlink:href="lly-20180331.xsd#OtherComprehensiveIncomeLossAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherComprehensiveIncomeLossReclassificationDetails" xlink:href="lly-20180331.xsd#OtherComprehensiveIncomeLossReclassificationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherComprehensiveIncomeLossTables" xlink:href="lly-20180331.xsd#OtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherComprehensiveIncomeLossTaxEffectDetails" xlink:href="lly-20180331.xsd#OtherComprehensiveIncomeLossTaxEffectDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherNetIncomeExpense" xlink:href="lly-20180331.xsd#OtherNetIncomeExpense" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherNetIncomeExpenseDetails" xlink:href="lly-20180331.xsd#OtherNetIncomeExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/OtherNetIncomeExpenseTables" xlink:href="lly-20180331.xsd#OtherNetIncomeExpenseTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/RetirementBenefits" xlink:href="lly-20180331.xsd#RetirementBenefits" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/RetirementBenefitsComponentsOfNetPeriodicBenefitCostDetails" xlink:href="lly-20180331.xsd#RetirementBenefitsComponentsOfNetPeriodicBenefitCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/RetirementBenefitsNarrativeDetails" xlink:href="lly-20180331.xsd#RetirementBenefitsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/RetirementBenefitsTables" xlink:href="lly-20180331.xsd#RetirementBenefitsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/SegmentInformation" xlink:href="lly-20180331.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/SegmentInformationNarrativeDetails" xlink:href="lly-20180331.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/SegmentInformationRevenueByProductDetails" xlink:href="lly-20180331.xsd#SegmentInformationRevenueByProductDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/SegmentInformationSegmentProfitDetails" xlink:href="lly-20180331.xsd#SegmentInformationSegmentProfitDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/SegmentInformationTables" xlink:href="lly-20180331.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ShareholdersEquity" xlink:href="lly-20180331.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.lilly.com/role/ShareholdersEquityDetails" xlink:href="lly-20180331.xsd#ShareholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.lilly.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_EC55743FE7DE5F94939DF5644DBB895C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_D20E1293EFFC587A85E770A13F4D8480" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_EC55743FE7DE5F94939DF5644DBB895C" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_D20E1293EFFC587A85E770A13F4D8480" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0AE90E606CBA034BEC8EF92CDAF5DFDA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB56196BA1DBA91C926DF92CDAF55E8E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0AE90E606CBA034BEC8EF92CDAF5DFDA" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB56196BA1DBA91C926DF92CDAF55E8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1609F6422149E18FC9D2F92CDAF5C630" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB56196BA1DBA91C926DF92CDAF55E8E" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1609F6422149E18FC9D2F92CDAF5C630" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0AF3ED7833FD41B3C13CF92CDAF55BBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1609F6422149E18FC9D2F92CDAF5C630" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0AF3ED7833FD41B3C13CF92CDAF55BBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_68DF0B47B58A636B634EF92CDAF5B8A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0AF3ED7833FD41B3C13CF92CDAF55BBE" xlink:to="loc_us-gaap_SubsequentEventMember_68DF0B47B58A636B634EF92CDAF5B8A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8DC0E3B63BF59CAB32B3F92CDAF5B704" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB56196BA1DBA91C926DF92CDAF55E8E" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8DC0E3B63BF59CAB32B3F92CDAF5B704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9B1FB305E68FF40F3766F92CDAF50608" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8DC0E3B63BF59CAB32B3F92CDAF5B704" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9B1FB305E68FF40F3766F92CDAF50608" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember" xlink:label="loc_lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember_7BBE60C44C54D752C0D3F92CDAF5E05C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9B1FB305E68FF40F3766F92CDAF50608" xlink:to="loc_lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember_7BBE60C44C54D752C0D3F92CDAF5E05C" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CoLucidPharmaceuticalsMember" xlink:label="loc_lly_CoLucidPharmaceuticalsMember_200F0F9E14174BF25DE3F92CDAF5C9A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9B1FB305E68FF40F3766F92CDAF50608" xlink:to="loc_lly_CoLucidPharmaceuticalsMember_200F0F9E14174BF25DE3F92CDAF5C9A8" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_SigilonTherapeuticsMember" xlink:label="loc_lly_SigilonTherapeuticsMember_A25EB692F1B8FACA0FE5F92CDAF5CA43" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9B1FB305E68FF40F3766F92CDAF50608" xlink:to="loc_lly_SigilonTherapeuticsMember_A25EB692F1B8FACA0FE5F92CDAF5CA43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DB56196BA1DBA91C926DF92CDAF55E8E" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquiredInProcessResearchAndDevelopment" xlink:label="loc_lly_AcquiredInProcessResearchAndDevelopment_A63B3CE76F8E668D9595F92CDAF5641A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:to="loc_lly_AcquiredInProcessResearchAndDevelopment_A63B3CE76F8E668D9595F92CDAF5641A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7062D4C0B66620327BA9F92CDAF5C8A3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7062D4C0B66620327BA9F92CDAF5C8A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F83D860E2924A84AB45AF92CDAF54E5A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F83D860E2924A84AB45AF92CDAF54E5A" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_PurchasedInProcessResearchAndDevelopment" xlink:label="loc_lly_PurchasedInProcessResearchAndDevelopment_1394C8BC033159965417F92CDAF56CDF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:to="loc_lly_PurchasedInProcessResearchAndDevelopment_1394C8BC033159965417F92CDAF56CDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_934308AE5C5A00EDF869F92CDAF5D492" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0F26D6754C642995398CF92CDAF5FCFD" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_934308AE5C5A00EDF869F92CDAF5D492" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AcquisitionsPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_A7B9A6A2508D56CF898B03F518DD0AE8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_C76BBFDEDCC957A994BC78DA6095A8DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_A7B9A6A2508D56CF898B03F518DD0AE8" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_C76BBFDEDCC957A994BC78DA6095A8DC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AcquisitionsPurchasedPriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_E41BDFA4F4C7FED04C3BFE8D9CE2C53B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_462F18358086612279B2FE8D9CE2B022" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_E41BDFA4F4C7FED04C3BFE8D9CE2C53B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_462F18358086612279B2FE8D9CE2B022" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4D76D81F13F27D5EAFD0FE8D9CE2846A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_462F18358086612279B2FE8D9CE2B022" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4D76D81F13F27D5EAFD0FE8D9CE2846A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_EF16C8FC0D8B2CC69ABEFE8D9CE2FB28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4D76D81F13F27D5EAFD0FE8D9CE2846A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_EF16C8FC0D8B2CC69ABEFE8D9CE2FB28" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember" xlink:label="loc_lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember_DB4A84F0083C3DE1D09DFE8D9CE2DDC7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_EF16C8FC0D8B2CC69ABEFE8D9CE2FB28" xlink:to="loc_lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember_DB4A84F0083C3DE1D09DFE8D9CE2DDC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_462F18358086612279B2FE8D9CE2B022" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_BDBB1B8179F7B695E54BFE8D9CE27E22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_BDBB1B8179F7B695E54BFE8D9CE27E22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8E9888DCD2043CFA9A61FE8D9CE25875" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8E9888DCD2043CFA9A61FE8D9CE25875" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0531A9B6261E50DEA1A2FE8D9CE2F5F0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0531A9B6261E50DEA1A2FE8D9CE2F5F0" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssetsandLiabilitiesNet" xlink:label="loc_lly_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssetsandLiabilitiesNet_C48A341EFE536FF27E1FFE8D9CE2A100" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_lly_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssetsandLiabilitiesNet_C48A341EFE536FF27E1FFE8D9CE2A100" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_78A6FC4512BBC783697BFE8D9CE3FE0F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_78A6FC4512BBC783697BFE8D9CE3FE0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_3A8096218DB32D197602FE8D9CE3E1CB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_us-gaap_Goodwill_3A8096218DB32D197602FE8D9CE3E1CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2C92DCB63090D85808B1FE8D9CE31521" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2C92DCB63090D85808B1FE8D9CE31521" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquiredInProcessResearchAndDevelopment" xlink:label="loc_lly_AcquiredInProcessResearchAndDevelopment_D7DE2B7E161DADDBA086FE8D9CE2E05C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_EF9C74120DDFD80095AFFE8D9CE28FB8" xlink:to="loc_lly_AcquiredInProcessResearchAndDevelopment_D7DE2B7E161DADDBA086FE8D9CE2E05C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_41D4C6067143CF75B802D1DC0EB75BA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E767A5A4FB230B8097D7D1DC0EB7DE2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_41D4C6067143CF75B802D1DC0EB75BA2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E767A5A4FB230B8097D7D1DC0EB7DE2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_41D12D56E0008EE91B25D1DC0EB78D57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E767A5A4FB230B8097D7D1DC0EB7DE2C" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_41D12D56E0008EE91B25D1DC0EB78D57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96FE7151E693820D405DD1DC0EB765C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_41D12D56E0008EE91B25D1DC0EB78D57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96FE7151E693820D405DD1DC0EB765C0" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember" xlink:label="loc_lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember_B9B7E6FB4C25868583A8D1DC0EB73C66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96FE7151E693820D405DD1DC0EB765C0" xlink:to="loc_lly_BoehringerIngelheimVetmedicaInc.sU.S.VaccinePortfolioMember_B9B7E6FB4C25868583A8D1DC0EB73C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_A35842C5D0A62BC07CD3D1DC0EB7DE94" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E767A5A4FB230B8097D7D1DC0EB7DE2C" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_A35842C5D0A62BC07CD3D1DC0EB7DE94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_BB1983947285246EDC38D1DC0EB7E6A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A35842C5D0A62BC07CD3D1DC0EB7DE94" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_BB1983947285246EDC38D1DC0EB7E6A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_85DC58D310C84982CEEED1DC0EB7C759" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A35842C5D0A62BC07CD3D1DC0EB7DE94" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_85DC58D310C84982CEEED1DC0EB7C759" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AssetImpairmentRestructuringAndOtherSpecialCharges" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7CDEA103905850C1B77CD76723BD41DA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock_7790F1973F6D51909422504C4C4A04F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7CDEA103905850C1B77CD76723BD41DA" xlink:to="loc_us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock_7790F1973F6D51909422504C4C4A04F8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AssetImpairmentRestructuringAndOtherSpecialChargesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_BEDFABC704FF8C2F83630330ACF8B804" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_37B1406BE4B2E6A6DE4A0330ACFA9E81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_BEDFABC704FF8C2F83630330ACF8B804" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_37B1406BE4B2E6A6DE4A0330ACFA9E81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_265908F9A897A1E6BBEE0330ACFBEE71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_37B1406BE4B2E6A6DE4A0330ACFA9E81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_265908F9A897A1E6BBEE0330ACFBEE71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_CE412F00FEA3369708260330ACFCAC5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_265908F9A897A1E6BBEE0330ACFBEE71" xlink:to="loc_us-gaap_SegmentDomain_CE412F00FEA3369708260330ACFCAC5E" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumanPharmaceuticalProductsMember" xlink:label="loc_lly_HumanPharmaceuticalProductsMember_B356D7A79AB7C0D43FA60330ACFC3196" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_CE412F00FEA3369708260330ACFCAC5E" xlink:to="loc_lly_HumanPharmaceuticalProductsMember_B356D7A79AB7C0D43FA60330ACFC3196" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AnimalHealthMember" xlink:label="loc_lly_AnimalHealthMember_FF21A017F1B036E672450330ACFE2D66" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_CE412F00FEA3369708260330ACFCAC5E" xlink:to="loc_lly_AnimalHealthMember_FF21A017F1B036E672450330ACFE2D66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_15D6F8F637592CF5441C0330ACFEF55C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_37B1406BE4B2E6A6DE4A0330ACFA9E81" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_15D6F8F637592CF5441C0330ACFEF55C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_237FE93053A16988E0230330ACFE1436" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_15D6F8F637592CF5441C0330ACFEF55C" xlink:to="loc_us-gaap_SeveranceCosts1_237FE93053A16988E0230330ACFE1436" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_235D9E289D5E47E154620330ACFE4F1A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_15D6F8F637592CF5441C0330ACFEF55C" xlink:to="loc_us-gaap_AssetImpairmentCharges_235D9E289D5E47E154620330ACFE4F1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_8A5202B7B67DF6C3A4080330ACFE47A0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_15D6F8F637592CF5441C0330ACFEF55C" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_8A5202B7B67DF6C3A4080330ACFE47A0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/AssetImpairmentRestructuringAndOtherSpecialChargesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_182963035A0DE238ACB4D1DC0E9110EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BEFDBC08DA6C1627191D1DC0E91CBBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_182963035A0DE238ACB4D1DC0E9110EF" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BEFDBC08DA6C1627191D1DC0E91CBBC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/BasisOfPresentationAndRevenue" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75D4C2D6257771FDE613CFA6F4447265" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_FBDFDC17F4B2F7E7A615CFA6F444EB8C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75D4C2D6257771FDE613CFA6F4447265" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_FBDFDC17F4B2F7E7A615CFA6F444EB8C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/BasisOfPresentationAndRevenueBasisOfPresentationAndRevenueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_60F7397DE9AF8B0D42AB07ABDB93BB30" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_60F7397DE9AF8B0D42AB07ABDB93BB30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_D58C62C2A497AA7CF7FF07ABDB935604" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:to="loc_us-gaap_OtherSalesRevenueNet_D58C62C2A497AA7CF7FF07ABDB935604" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_C58AE5B8AB759A0BE8DB07ABDB93ED30" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:to="loc_us-gaap_Revenues_C58AE5B8AB759A0BE8DB07ABDB93ED30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7CD090B91E935556CA8907ABDB932DB5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7CD090B91E935556CA8907ABDB932DB5" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_RevenuefromContractPaymentTermMinimum" xlink:label="loc_lly_RevenuefromContractPaymentTermMinimum_3A7EEB92A40D3459882207ABDB9336D6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:to="loc_lly_RevenuefromContractPaymentTermMinimum_3A7EEB92A40D3459882207ABDB9336D6" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_RevenuefromContractPaymentTermMaximum" xlink:label="loc_lly_RevenuefromContractPaymentTermMaximum_08E22BDC1AF716D77F3B07ABDB93A12C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ED4036C93187A69B0F2D07ABDB933D6A" xlink:to="loc_lly_RevenuefromContractPaymentTermMaximum_08E22BDC1AF716D77F3B07ABDB93A12C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/BasisOfPresentationAndRevenueBasisOfPresentationAndRevenueTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E84E42C8AA054528F8FED1DC0ED0332D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_2ED4FDCBF9A08E87FB2CD1DC0ED0FA98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E84E42C8AA054528F8FED1DC0ED0332D" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_2ED4FDCBF9A08E87FB2CD1DC0ED0FA98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_FDAC15287CF629AE1F04D1DC0ED089D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_E84E42C8AA054528F8FED1DC0ED0332D" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_FDAC15287CF629AE1F04D1DC0ED089D1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/CollaborationsAndOtherArrangements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CB30DE6CDC0F5E029479C75FDEAA5382" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_B1C4F2B0016F55509BBB4459EA581841" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CB30DE6CDC0F5E029479C75FDEAA5382" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_B1C4F2B0016F55509BBB4459EA581841" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/CollaborationsAndOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2D25507A8BBD9E5E47690709CF8571B0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2D25507A8BBD9E5E47690709CF8571B0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_0BBACE7A8349154824EA0709CF850798" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:to="loc_us-gaap_StatementGeographicalAxis_0BBACE7A8349154824EA0709CF850798" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_D7305C2AECD3E3C9335E0709CF853F27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_0BBACE7A8349154824EA0709CF850798" xlink:to="loc_us-gaap_SegmentGeographicalDomain_D7305C2AECD3E3C9335E0709CF853F27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EuropeMember" xlink:label="loc_us-gaap_EuropeMember_D78B5221D3DE834B9CB80709CF855F15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_D7305C2AECD3E3C9335E0709CF853F27" xlink:to="loc_us-gaap_EuropeMember_D78B5221D3DE834B9CB80709CF855F15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="loc_country_JP_28B5E8DB3906632FD8B80709CF853FD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_D7305C2AECD3E3C9335E0709CF853F27" xlink:to="loc_country_JP_28B5E8DB3906632FD8B80709CF853FD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_550EC7E0994F0828FCA40709CF85D539" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_550EC7E0994F0828FCA40709CF85D539" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_C46DB781A4EB1925DFF60709CF8BD116" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_550EC7E0994F0828FCA40709CF85D539" xlink:to="loc_us-gaap_SegmentDomain_C46DB781A4EB1925DFF60709CF8BD116" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumanPharmaceuticalProductsMember" xlink:label="loc_lly_HumanPharmaceuticalProductsMember_B3C7868825DBA6C8B3B80709CF8B4468" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_C46DB781A4EB1925DFF60709CF8BD116" xlink:to="loc_lly_HumanPharmaceuticalProductsMember_B3C7868825DBA6C8B3B80709CF8B4468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3D1CF1063ED95C9B7A360709CF8BF1D3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3D1CF1063ED95C9B7A360709CF8BF1D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3D1CF1063ED95C9B7A360709CF8BF1D3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember" xlink:label="loc_lly_MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember_0216E84875EFFD0FCCA40709CF8BF61B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulativeMember_0216E84875EFFD0FCCA40709CF8BF61B" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquisitionTermsContingentConsiderationMember" xlink:label="loc_lly_AcquisitionTermsContingentConsiderationMember_7BB58A77DD1A4B29E5030709CF8BFF3A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_AcquisitionTermsContingentConsiderationMember_7BB58A77DD1A4B29E5030709CF8BFF3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="loc_us-gaap_RoyaltyAgreementTermsMember_A29E28DA5225E615F3D10709CF8BA10B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_us-gaap_RoyaltyAgreementTermsMember_A29E28DA5225E615F3D10709CF8BA10B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ECE60CD7EDB7C6C261170709CF8B769F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ECE60CD7EDB7C6C261170709CF8B769F" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MilestonePaymentsDevelopmentandRegulatoryExpensedMember" xlink:label="loc_lly_MilestonePaymentsDevelopmentandRegulatoryExpensedMember_18F06EE57C513D24E8160709CF8B8441" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_MilestonePaymentsDevelopmentandRegulatoryExpensedMember_18F06EE57C513D24E8160709CF8B8441" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredMember" xlink:label="loc_lly_MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredMember_4ABEF9C8ABE89FAB21620709CF8BB63A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredMember_4ABEF9C8ABE89FAB21620709CF8BB63A" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MilestonePaymentsDevelopmentAndRegulatoryMember" xlink:label="loc_lly_MilestonePaymentsDevelopmentAndRegulatoryMember_F15C098E72BAE12C15580709CF8B414B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_MilestonePaymentsDevelopmentAndRegulatoryMember_F15C098E72BAE12C15580709CF8B414B" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MilestonePaymentsDevelopmentandRegulatoryFirstIndicationMember" xlink:label="loc_lly_MilestonePaymentsDevelopmentandRegulatoryFirstIndicationMember_13D105224773AF962F300709CF8B65CB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_MilestonePaymentsDevelopmentandRegulatoryFirstIndicationMember_13D105224773AF962F300709CF8B65CB" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MilestonePaymentsSalesBasedMember" xlink:label="loc_lly_MilestonePaymentsSalesBasedMember_172B075B25A135096CBC0709CF8B936B" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_MilestonePaymentsSalesBasedMember_172B075B25A135096CBC0709CF8B936B" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ProfitAndDevelopmentAndMarketingShareMember" xlink:label="loc_lly_ProfitAndDevelopmentAndMarketingShareMember_D9405A445F924BAAE0A10709CF8B5DBB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_CCAC165AADEE9548B2910709CF8BC540" xlink:to="loc_lly_ProfitAndDevelopmentAndMarketingShareMember_D9405A445F924BAAE0A10709CF8B5DBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_1D0C7BCCA98D0160A07C0709CF8B5437" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:to="loc_us-gaap_ProductOrServiceAxis_1D0C7BCCA98D0160A07C0709CF8B5437" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_1D0C7BCCA98D0160A07C0709CF8B5437" xlink:to="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BiCompoundsMember" xlink:label="loc_lly_BiCompoundsMember_747BAAE3A1ACC06F45020709CF8C932C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_BiCompoundsMember_747BAAE3A1ACC06F45020709CF8C932C" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BasaglarMember" xlink:label="loc_lly_BasaglarMember_972B393F510A07151EB90709CF8CD4B4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_BasaglarMember_972B393F510A07151EB90709CF8CD4B4" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ErbituxMember" xlink:label="loc_lly_ErbituxMember_C5A398CFCBBA6BE270740709CF8CA79D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_ErbituxMember_C5A398CFCBBA6BE270740709CF8CA79D" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EffientMember" xlink:label="loc_lly_EffientMember_F54344B9BA776817DD6E0709CF8C6BAF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_EffientMember_F54344B9BA776817DD6E0709CF8C6BAF" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_TrajentaBIMember" xlink:label="loc_lly_TrajentaBIMember_C73239E8551C14C0DEF30709CF8C5137" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_TrajentaBIMember_C73239E8551C14C0DEF30709CF8C5137" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_JardianceBIMember" xlink:label="loc_lly_JardianceBIMember_D3B5CA5059FD7A837FA70709CF8C7353" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_JardianceBIMember_D3B5CA5059FD7A837FA70709CF8C7353" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OlumiantMember" xlink:label="loc_lly_OlumiantMember_BA15E3C072BD0566535B0709CF8C0880" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_OlumiantMember_BA15E3C072BD0566535B0709CF8C0880" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_TanezumabMember" xlink:label="loc_lly_TanezumabMember_3118182EC2E567C1831F0709CF8C87C6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_TanezumabMember_3118182EC2E567C1831F0709CF8C87C6" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_LanabecestatMember" xlink:label="loc_lly_LanabecestatMember_B8BA7A29A8DF79FB7D320709CF8CEAFD" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_460A6A4737E8DA3028090709CF8B678B" xlink:to="loc_lly_LanabecestatMember_B8BA7A29A8DF79FB7D320709CF8CEAFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_BB15567B2AAD166F85410709CF855E5A" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CollaborativeArrangementRightsAndObligationsTerms" xlink:label="loc_lly_CollaborativeArrangementRightsAndObligationsTerms_5B62E8B50D69231C1D660709CF8C2B69" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:to="loc_lly_CollaborativeArrangementRightsAndObligationsTerms_5B62E8B50D69231C1D660709CF8C2B69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_37783E0E05B128D74EA10709CF8C3CF2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:to="loc_us-gaap_Revenues_37783E0E05B128D74EA10709CF8C3CF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_38C515ECB70CF9DB94750709CF8C5319" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:to="loc_us-gaap_OtherSalesRevenueNet_38C515ECB70CF9DB94750709CF8C5319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_7AEBD9661292CC0CDFA60709CF8CA703" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_7AEBD9661292CC0CDFA60709CF8CA703" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4C6D147584A42110C5A10709CF8C80B3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4C6D147584A42110C5A10709CF8C80B3" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CollaborativeArrangementRightsAndObligationsPercent" xlink:label="loc_lly_CollaborativeArrangementRightsAndObligationsPercent_537B3D13A49A3F91D6C90709CF8CD1F6" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_950B522B0293182412DA0709CF8C2F4A" xlink:to="loc_lly_CollaborativeArrangementRightsAndObligationsPercent_537B3D13A49A3F91D6C90709CF8CD1F6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/CollaborationsAndOtherArrangementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_F1AE3519694F0476BEC2D1DC0EA52FAD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2F8DB53BB39336E6C1E1D1DC0EA5D931" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_F1AE3519694F0476BEC2D1DC0EA52FAD" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2F8DB53BB39336E6C1E1D1DC0EA5D931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_815FB2921EDB41E8D4ABD1DC0EA5616A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2F8DB53BB39336E6C1E1D1DC0EA5D931" xlink:to="loc_us-gaap_ProductOrServiceAxis_815FB2921EDB41E8D4ABD1DC0EA5616A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_D15283FC393D3B275A35D1DC0EA503AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_815FB2921EDB41E8D4ABD1DC0EA5616A" xlink:to="loc_us-gaap_ProductsAndServicesDomain_D15283FC393D3B275A35D1DC0EA503AD" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_DiabetesCollaborationMember" xlink:label="loc_lly_DiabetesCollaborationMember_7D56131D69110EF08A83D1DC0EA5BAA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D15283FC393D3B275A35D1DC0EA503AD" xlink:to="loc_lly_DiabetesCollaborationMember_7D56131D69110EF08A83D1DC0EA5BAA7" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BiCompoundsMember" xlink:label="loc_lly_BiCompoundsMember_1E4F909D0168C3A986FAD1DC0EA581E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D15283FC393D3B275A35D1DC0EA503AD" xlink:to="loc_lly_BiCompoundsMember_1E4F909D0168C3A986FAD1DC0EA581E6" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ErbituxMember" xlink:label="loc_lly_ErbituxMember_F931C90669E213C6C8ECD1DC0EA51C4D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D15283FC393D3B275A35D1DC0EA503AD" xlink:to="loc_lly_ErbituxMember_F931C90669E213C6C8ECD1DC0EA51C4D" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EffientMember" xlink:label="loc_lly_EffientMember_15B8DD5B3ED69CA22081D1DC0EA50955" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_D15283FC393D3B275A35D1DC0EA503AD" xlink:to="loc_lly_EffientMember_15B8DD5B3ED69CA22081D1DC0EA50955" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_29E1CD4611DC73A09FABD1DC0EA5C39F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2F8DB53BB39336E6C1E1D1DC0EA5D931" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_29E1CD4611DC73A09FABD1DC0EA5C39F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_8E6AD2F4974B3B098900D1DC0EA5418D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_29E1CD4611DC73A09FABD1DC0EA5C39F" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_8E6AD2F4974B3B098900D1DC0EA5418D" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ScheduleofMarketingRightsTableTextBlock" xlink:label="loc_lly_ScheduleofMarketingRightsTableTextBlock_DC12A1243B7DA340B5D5D1DC0EA5D9CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_29E1CD4611DC73A09FABD1DC0EA5C39F" xlink:to="loc_lly_ScheduleofMarketingRightsTableTextBlock_DC12A1243B7DA340B5D5D1DC0EA5D9CB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ConsolidatedCondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_59F44037AA76DBBBBA4AFE8D9D12347D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_716047931927D5E77925FE8D9D129E0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_59F44037AA76DBBBBA4AFE8D9D12347D" xlink:to="loc_us-gaap_AssetsAbstract_716047931927D5E77925FE8D9D129E0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_716047931927D5E77925FE8D9D129E0D" xlink:to="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D76C531B1F908B6B9786FE8D9D13576B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D76C531B1F908B6B9786FE8D9D13576B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaap_ShortTermInvestments_0692A287D2A2AB4ADCC2FE8D9D13D106" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_ShortTermInvestments_0692A287D2A2AB4ADCC2FE8D9D13D106" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_393A840D74034E071010FE8D9D13B3AA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_393A840D74034E071010FE8D9D13B3AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_299034F55C9C3F509AFCFE8D9D138553" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_299034F55C9C3F509AFCFE8D9D138553" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A71B920F814F20BC4809FE8D9D139A21" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_InventoryNet_A71B920F814F20BC4809FE8D9D139A21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_C1C138F90127737A3DAAFE8D9D137798" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_C1C138F90127737A3DAAFE8D9D137798" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_02A98D0C41AFD7442520FE8D9D13A3B6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18A51744AF534E36C37DFE8D9D12F61A" xlink:to="loc_us-gaap_AssetsCurrent_02A98D0C41AFD7442520FE8D9D13A3B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_716047931927D5E77925FE8D9D129E0D" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaap_LongTermInvestments_0436565CB36163D3665AFE8D9D13441E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:to="loc_us-gaap_LongTermInvestments_0436565CB36163D3665AFE8D9D13441E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_5484CFA41AD5FF7472BDFE8D9D139A3E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:to="loc_us-gaap_Goodwill_5484CFA41AD5FF7472BDFE8D9D139A3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58FFC987AD2707B7ABF1FE8D9D13DD9B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58FFC987AD2707B7ABF1FE8D9D13DD9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4693AEB5637DBA11CBEBFE8D9D13EFB3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4693AEB5637DBA11CBEBFE8D9D13EFB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7792062CE22DD5AA9477FE8D9D13EAA4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7792062CE22DD5AA9477FE8D9D13EAA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_26750475A5E87BF1D3FDFE8D9D1375CE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8D7F7A356E08530A68DCFE8D9D13223B" xlink:to="loc_us-gaap_AssetsNoncurrent_26750475A5E87BF1D3FDFE8D9D1375CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_D3A60B7EC3946144B621FE8D9D131848" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_716047931927D5E77925FE8D9D129E0D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_D3A60B7EC3946144B621FE8D9D131848" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_FE94F223CEA44A135F4EFE8D9D132DA4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_716047931927D5E77925FE8D9D129E0D" xlink:to="loc_us-gaap_Assets_FE94F223CEA44A135F4EFE8D9D132DA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CBCB0856D72E6C60C22EFE8D9D132583" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_59F44037AA76DBBBBA4AFE8D9D12347D" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CBCB0856D72E6C60C22EFE8D9D132583" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CBCB0856D72E6C60C22EFE8D9D132583" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_E515ABE87902A1968745FE8D9D149233" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_DebtCurrent_E515ABE87902A1968745FE8D9D149233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_EEEBA316877E9D55ED52FE8D9D505F64" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_AccountsPayableCurrent_EEEBA316877E9D55ED52FE8D9D505F64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_D27F620DBEC8E79CBBAEFE8D9D504776" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_D27F620DBEC8E79CBBAEFE8D9D504776" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_SalesRebatesAndDiscounts" xlink:label="loc_lly_SalesRebatesAndDiscounts_14E4C77D914EF464220FFE8D9D5040CA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_lly_SalesRebatesAndDiscounts_14E4C77D914EF464220FFE8D9D5040CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaap_DividendsPayableCurrent_2204A8CFC1C2DB03FA87FE8D9D50B6A4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_DividendsPayableCurrent_2204A8CFC1C2DB03FA87FE8D9D50B6A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaap_TaxesPayableCurrent_7F1D02185056179DBCB3FE8D9D508728" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_TaxesPayableCurrent_7F1D02185056179DBCB3FE8D9D508728" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_76A6AB3548D71C153CF1FE8D9D5020B4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_76A6AB3548D71C153CF1FE8D9D5020B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_63BB50F5D7D253B4B979FE8D9D50BE3B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1566089D24BBD67F88D5FE8D9D130244" xlink:to="loc_us-gaap_LiabilitiesCurrent_63BB50F5D7D253B4B979FE8D9D50BE3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CBCB0856D72E6C60C22EFE8D9D132583" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_FE06B83F31B2CEF5741DFE8D9D50C633" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_FE06B83F31B2CEF5741DFE8D9D50C633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ECD6BCD26375811C483DFE8D9D50D15A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ECD6BCD26375811C483DFE8D9D50D15A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_961ABCAE19CB46270C1DFE8D9D5127DE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_961ABCAE19CB46270C1DFE8D9D5127DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_F7F7F71300330B89D7D5FE8D9D51AFC0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_F7F7F71300330B89D7D5FE8D9D51AFC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_A3068AAE63B1977923D8FE8D9D518DF6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_7851B284E7D9D069FD05FE8D9D508DF6" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_A3068AAE63B1977923D8FE8D9D518DF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CBCB0856D72E6C60C22EFE8D9D132583" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_4D82D978D5F18F41886BFE8D9D5102E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_CommonStockValue_4D82D978D5F18F41886BFE8D9D5102E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_76D3B3CC4A4B66563D8EFE8D9D51CEFE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_76D3B3CC4A4B66563D8EFE8D9D51CEFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_DDFF3502A6E955AD4EE1FE8D9D51996D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_DDFF3502A6E955AD4EE1FE8D9D51996D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrust" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrust_EF45E7FE02A4424498A0FE8D9D51FCF5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_CommonStockSharesHeldInEmployeeTrust_EF45E7FE02A4424498A0FE8D9D51FCF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_359D4CC695B4332EA076FE8D9D51541F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_359D4CC695B4332EA076FE8D9D51541F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E1243BA02649D9C725B3FE8D9D51A09D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_TreasuryStockValue_E1243BA02649D9C725B3FE8D9D51A09D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_B225205CD17D3C8E653FFE8D9D510619" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_StockholdersEquity_B225205CD17D3C8E653FFE8D9D510619" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_683E454130E0C22FF412FE8D9D51E99D" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_MinorityInterest_683E454130E0C22FF412FE8D9D51E99D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_910CB3B26403942A2297FE8D9D510584" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_D64FE12BFC91C5423C7FFE8D9D51D457" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_910CB3B26403942A2297FE8D9D510584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_D5B3AFFB68249EDBEF8CFE8D9D510E25" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CBCB0856D72E6C60C22EFE8D9D132583" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_D5B3AFFB68249EDBEF8CFE8D9D510E25" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract_DDADDC071317C01D34F007250F871E64" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7CF1EEB634BE243CD77607250F872406" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_DDADDC071317C01D34F007250F871E64" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7CF1EEB634BE243CD77607250F872406" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_DFA0966447C0DB1AFFEB07250F87302B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_DDADDC071317C01D34F007250F871E64" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_DFA0966447C0DB1AFFEB07250F87302B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72958AE5CEBCD1408369F099B1316BAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72958AE5CEBCD1408369F099B1316BAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_C90A5712FA17CFB6A88DF099B1314BA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72958AE5CEBCD1408369F099B1316BAB" xlink:to="loc_us-gaap_NetIncomeLoss_C90A5712FA17CFB6A88DF099B1314BA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72958AE5CEBCD1408369F099B1316BAB" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_070C75F87E9CE71DC141F099B131D162" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_070C75F87E9CE71DC141F099B131D162" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_8A6FAD1A42E7790E181BF099B13208F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_8A6FAD1A42E7790E181BF099B13208F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_37961DEB22231172B9D2F099B1326537" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:to="loc_us-gaap_ShareBasedCompensation_37961DEB22231172B9D2F099B1326537" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquiredInProcessResearchAndDevelopment" xlink:label="loc_lly_AcquiredInProcessResearchAndDevelopment_D6BCE974D6BCBC985735F099B132E141" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:to="loc_lly_AcquiredInProcessResearchAndDevelopment_D6BCE974D6BCBC985735F099B132E141" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_475EC053270A2A36F3C2F099B13210C2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_475EC053270A2A36F3C2F099B13210C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_BA6EA68124FEC6DBDB5AF099B1322880" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_B19560F18CB393145FD9F099B1310AD5" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_BA6EA68124FEC6DBDB5AF099B1322880" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2F33666CDF4095244FCEF099B13274D7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_72958AE5CEBCD1408369F099B1316BAB" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2F33666CDF4095244FCEF099B13274D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_CF757E5A1B3DCFAEC11BF099B1328052" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_CF757E5A1B3DCFAEC11BF099B1328052" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_A3961BB8F05D204C4590F099B1324619" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_A3961BB8F05D204C4590F099B1324619" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_08E608876E4E4CAC7DDEF099B1324B23" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_08E608876E4E4CAC7DDEF099B1324B23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_3EB8E42BB3D7F3063D0FF099B132B0E6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_3EB8E42BB3D7F3063D0FF099B132B0E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_ADCE1D0C32BE5EA73004F099B132071E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_ADCE1D0C32BE5EA73004F099B132071E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_450DF54B7D224CBD1517F099B1325776" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_450DF54B7D224CBD1517F099B1325776" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_PurchasedInProcessResearchAndDevelopment" xlink:label="loc_lly_PurchasedInProcessResearchAndDevelopment_0F162D39A58A9BA19F84F099B132FA8A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_lly_PurchasedInProcessResearchAndDevelopment_0F162D39A58A9BA19F84F099B132FA8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6B943CB9ECFF8E88AE12F099B13263F9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6B943CB9ECFF8E88AE12F099B13263F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_F5B4C0F21EBABF7E0206F099B1324161" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3A9B42851685A64297EEF099B132E4C4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_F5B4C0F21EBABF7E0206F099B1324161" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_EBB355E66B6BED2C2871F099B133DE4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:to="loc_us-gaap_PaymentsOfDividends_EBB355E66B6BED2C2871F099B133DE4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_2110EE4A088A7EAE8E66F099B1332F89" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_2110EE4A088A7EAE8E66F099B1332F89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_942867B8B95747C5A3BCF099B1330234" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_942867B8B95747C5A3BCF099B1330234" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57A2C74CA7ECA05367AEF099B13307E4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_57A2C74CA7ECA05367AEF099B13307E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A646B67968DCBA71A243F099B13359FF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_A646B67968DCBA71A243F099B13359FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_BCB3B15231C5C5068613F099B133559B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_D315E90C1043666E5316F099B133FB5B" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_BCB3B15231C5C5068613F099B133559B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1B3421D204816139C6E8F099B13310A8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1B3421D204816139C6E8F099B13310A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_5D3E9E2B1B1987E9737BF099B1333EA7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_5D3E9E2B1B1987E9737BF099B1333EA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_78EFE53F346BA96042D8F099B1331A72" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_78EFE53F346BA96042D8F099B1331A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_EA5F1DA8BD14C3AF5EA7F099B133A258" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0AD149726C0A5E4FE365F099B1315BD6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_EA5F1DA8BD14C3AF5EA7F099B133A258" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1D6A008BD2F3F581563BF02C6AA0DA41" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9C9A46C6BA04784395C3F02C6AA059ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1D6A008BD2F3F581563BF02C6AA0DA41" xlink:to="loc_us-gaap_NetIncomeLoss_9C9A46C6BA04784395C3F02C6AA059ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_E2B63EA560A934F6B048F02C6AA19B69" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1D6A008BD2F3F581563BF02C6AA0DA41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_E2B63EA560A934F6B048F02C6AA19B69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_28C51663415450CB2F9AF02C6AA10150" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1D6A008BD2F3F581563BF02C6AA0DA41" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_28C51663415450CB2F9AF02C6AA10150" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfComprehensiveIncomeUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2D024BE5535E4EADD953FE8D9D54FE97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9D7A3B38A5A710E853AAFE8D9D54BDEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2D024BE5535E4EADD953FE8D9D54FE97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9D7A3B38A5A710E853AAFE8D9D54BDEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_D59CFBA3E7FCF6F67B57FE8D9D541703" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2D024BE5535E4EADD953FE8D9D54FE97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_D59CFBA3E7FCF6F67B57FE8D9D541703" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ConsolidatedCondensedStatementsOfOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_CB7E78C8EF01D2F3BFCEF02C6AA68A53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_Revenues_CB7E78C8EF01D2F3BFCEF02C6AA68A53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_72FF55D7952061C635FBF02C6AA657C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_us-gaap_CostOfGoodsSold_72FF55D7952061C635FBF02C6AA657C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_560939B2FAF16352ED08F02C6AA691AF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_560939B2FAF16352ED08F02C6AA691AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_463EC4A899FC1356F6E2F02C6AA68D44" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_463EC4A899FC1356F6E2F02C6AA68D44" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquiredInProcessResearchAndDevelopment" xlink:label="loc_lly_AcquiredInProcessResearchAndDevelopment_68168C595C090EE5B656F02C6AA6E46A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_lly_AcquiredInProcessResearchAndDevelopment_68168C595C090EE5B656F02C6AA6E46A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_E6457FD940D3A30636A6F02C6AA674F2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_E6457FD940D3A30636A6F02C6AA674F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3DD1AEC4A510EBEF8D27F02C6AA621DA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3DD1AEC4A510EBEF8D27F02C6AA621DA" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CostOfSalesOperatingExpensesAndOtherNet" xlink:label="loc_lly_CostOfSalesOperatingExpensesAndOtherNet_244EC878F06A7193A786F02C6AA6EFD0" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_00C0C8B7D35FBF7EBFB8F02C6AA601E8" xlink:to="loc_lly_CostOfSalesOperatingExpensesAndOtherNet_244EC878F06A7193A786F02C6AA6EFD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13A1F945D3EB8727C2B1F02C6AA6E3A2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13A1F945D3EB8727C2B1F02C6AA6E3A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_754245E2ECC119A38DA7F02C6AA63EF0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_754245E2ECC119A38DA7F02C6AA63EF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_76A504364A3FDCD41F23F02C6AA6B557" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_NetIncomeLoss_76A504364A3FDCD41F23F02C6AA6B557" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_35A39A1ABAA086A20AFFF02C6AA7AAF3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_EarningsPerShareAbstract_35A39A1ABAA086A20AFFF02C6AA7AAF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_B966607E3941229CC686F02C6AA786B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35A39A1ABAA086A20AFFF02C6AA7AAF3" xlink:to="loc_us-gaap_EarningsPerShareBasic_B966607E3941229CC686F02C6AA786B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_48A5ABED7A6EA64C6123F02C6AA7BB40" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_35A39A1ABAA086A20AFFF02C6AA7AAF3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_48A5ABED7A6EA64C6123F02C6AA7BB40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B2EF3968E2C58971B4FDF02C6AA754E5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B2EF3968E2C58971B4FDF02C6AA754E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1D5CF2DD42DBDF9B8FE7F02C6AA747B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B2EF3968E2C58971B4FDF02C6AA754E5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1D5CF2DD42DBDF9B8FE7F02C6AA747B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7498178FE46F964EEC90F02C6AA7227E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B2EF3968E2C58971B4FDF02C6AA754E5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7498178FE46F964EEC90F02C6AA7227E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_D43BD74F12445C4E2FB3F02C6AA7902A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0A88FE5719230E77C525F02C6AA69803" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_D43BD74F12445C4E2FB3F02C6AA7902A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9EB301D144DC5035B07E9B0FD15D7652" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_25807FB8F57153E1B79922B5A9F7D76A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9EB301D144DC5035B07E9B0FD15D7652" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_25807FB8F57153E1B79922B5A9F7D76A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D80C366B3A7DE818929042239A5F185" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D80C366B3A7DE818929042239A5F185" xlink:to="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_D5B097FD4A82409B1791042239A8332D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_D5B097FD4A82409B1791042239A8332D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_C43736EC8790A206C636042239A8DD58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_D5B097FD4A82409B1791042239A8332D" xlink:to="loc_us-gaap_LossContingencyNatureDomain_C43736EC8790A206C636042239A8DD58" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ProductLiabilityLitigationMember" xlink:label="loc_lly_ProductLiabilityLitigationMember_8BBB4D707B8A7277265A042239A8361B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_C43736EC8790A206C636042239A8DD58" xlink:to="loc_lly_ProductLiabilityLitigationMember_8BBB4D707B8A7277265A042239A8361B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseAxis" xlink:label="loc_us-gaap_LitigationCaseAxis_55A06427B51B76356483042239A80A45" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:to="loc_us-gaap_LitigationCaseAxis_55A06427B51B76356483042239A80A45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_E5EB45E94AA930B37AA0042239A8B5AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseAxis_55A06427B51B76356483042239A80A45" xlink:to="loc_us-gaap_LitigationCaseTypeDomain_E5EB45E94AA930B37AA0042239A8B5AB" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_E5EB45E94AA930B37AA0042239A8B5AB" xlink:to="loc_lly_ProductLiabilityLitigationMember_8BBB4D707B8A7277265A042239A8361B" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_TakedaPortionMember" xlink:label="loc_lly_TakedaPortionMember_C2F13120A6D5CE4905FB042239A88FD6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_E5EB45E94AA930B37AA0042239A8B5AB" xlink:to="loc_lly_TakedaPortionMember_C2F13120A6D5CE4905FB042239A88FD6" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EmployeeLitigationMember" xlink:label="loc_lly_EmployeeLitigationMember_5CB0720E0C47B87828D0042239A86902" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_E5EB45E94AA930B37AA0042239A8B5AB" xlink:to="loc_lly_EmployeeLitigationMember_5CB0720E0C47B87828D0042239A86902" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EmployeeLitigationRulinginAprilTwentyEighteenMember" xlink:label="loc_lly_EmployeeLitigationRulinginAprilTwentyEighteenMember_2588B80227010B2024090422F3F977A1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_E5EB45E94AA930B37AA0042239A8B5AB" xlink:to="loc_lly_EmployeeLitigationRulinginAprilTwentyEighteenMember_2588B80227010B2024090422F3F977A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_033865200C3ADDC88BA2042239A9DE67" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:to="loc_us-gaap_StatementGeographicalAxis_033865200C3ADDC88BA2042239A9DE67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_033865200C3ADDC88BA2042239A9DE67" xlink:to="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_E67968ABB968F60B0860042239AEA677" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_country_US_E67968ABB968F60B0860042239AEA677" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CA" xlink:label="loc_country_CA_C649CDC9D6819A2D23C2042239AE64FD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_country_CA_C649CDC9D6819A2D23C2042239AE64FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_A6" xlink:label="loc_stpr_A6_5DEC3A602AFCF18B23D7042239AEDFC5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_stpr_A6_5DEC3A602AFCF18B23D7042239AEDFC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_A8" xlink:label="loc_stpr_A8_7C819AB5DE55812FFBF4042239AE0E67" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_stpr_A8_7C819AB5DE55812FFBF4042239AE0E67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_A0" xlink:label="loc_stpr_A0_510033823D10B07BC0DC042239AE2FE6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_stpr_A0_510033823D10B07BC0DC042239AE2FE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:label="loc_stpr_CA_509A23AC94C1B8AE933E042239AE91D1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_stpr_CA_509A23AC94C1B8AE933E042239AE91D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_BR" xlink:label="loc_country_BR_17F05ACC1C4C5AC360C1042239AEE998" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_B79ABD452FE14FD809A4042239AE5878" xlink:to="loc_country_BR_17F05ACC1C4C5AC360C1042239AEE998" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_4C0A50135F96E7E60BA8042239AE5B94" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:to="loc_us-gaap_ProductOrServiceAxis_4C0A50135F96E7E60BA8042239AE5B94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_730E21108546E0AA6EBB042239AE3985" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_4C0A50135F96E7E60BA8042239AE5B94" xlink:to="loc_us-gaap_ProductsAndServicesDomain_730E21108546E0AA6EBB042239AE3985" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AlimtaMember" xlink:label="loc_lly_AlimtaMember_1C90466CC996A23BF6A4042239AEA341" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_730E21108546E0AA6EBB042239AE3985" xlink:to="loc_lly_AlimtaMember_1C90466CC996A23BF6A4042239AEA341" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ActosMember" xlink:label="loc_lly_ActosMember_5B87E2B6F80D0E3AF6E6042239AEED65" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_730E21108546E0AA6EBB042239AE3985" xlink:to="loc_lly_ActosMember_5B87E2B6F80D0E3AF6E6042239AEED65" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CymbaltaMember" xlink:label="loc_lly_CymbaltaMember_5E02CC2133F7A7794B14042239AF79D2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_730E21108546E0AA6EBB042239AE3985" xlink:to="loc_lly_CymbaltaMember_5E02CC2133F7A7794B14042239AF79D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09F25B2F0174F7D562D5042239A7D97F" xlink:to="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_NumberofNewApplication" xlink:label="loc_lly_NumberofNewApplication_9A36CEDC7D874F97B55F042239AFCFEE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_lly_NumberofNewApplication_9A36CEDC7D874F97B55F042239AFCFEE" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_LossContingencyNumberOfCases" xlink:label="loc_lly_LossContingencyNumberOfCases_35AB31C4E0D279B1B5E4042239AFBA73" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_lly_LossContingencyNumberOfCases_35AB31C4E0D279B1B5E4042239AFBA73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_385D605384EAC61AA18F042239AF55B3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_385D605384EAC61AA18F042239AF55B3" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_LossContingencyNumberOfLawsuits" xlink:label="loc_lly_LossContingencyNumberOfLawsuits_3E7B7CA8B986581B79FF042239AF2428" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_lly_LossContingencyNumberOfLawsuits_3E7B7CA8B986581B79FF042239AF2428" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_9E41090C4F6EBFE79176042239AF20C8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_9E41090C4F6EBFE79176042239AF20C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_25908D2B5C75D5DF1000042239AFA874" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_25908D2B5C75D5DF1000042239AFA874" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_NumberofIndividuals" xlink:label="loc_lly_NumberofIndividuals_978CE6F9649C67D5E2BC042239AF62BB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_17F0C7E114F0B565F7B4042239AF6970" xlink:to="loc_lly_NumberofIndividuals_978CE6F9649C67D5E2BC042239AF62BB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="lly-20180331.xsd#lly_DocumentEntityInformationAbstract" xlink:label="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_E1C77D82DB8D54659B5E1674C3FB842F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_DocumentType_E1C77D82DB8D54659B5E1674C3FB842F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9B381F945A8651BC9F39613D5729FA6A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_AmendmentFlag_9B381F945A8651BC9F39613D5729FA6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7D69892BA430572BA85DB5876C6DAF9D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_DocumentPeriodEndDate_7D69892BA430572BA85DB5876C6DAF9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_243A52DA6F115FCD90AF125A62387281" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_DocumentFiscalYearFocus_243A52DA6F115FCD90AF125A62387281" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_A99C1B1D853B55C7B10880321132D967" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_DocumentFiscalPeriodFocus_A99C1B1D853B55C7B10880321132D967" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F50BF669A58855508BD8045EDB1FDBE3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_EntityRegistrantName_F50BF669A58855508BD8045EDB1FDBE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_B2527F58126F54B8BD0D5142FFB490AB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_EntityCentralIndexKey_B2527F58126F54B8BD0D5142FFB490AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_7C84C49D9968577D9FAE67B06B2C8292" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_CurrentFiscalYearEndDate_7C84C49D9968577D9FAE67B06B2C8292" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_9E22DE5397B454AA838D87CEC464CA5A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_EntityVoluntaryFilers_9E22DE5397B454AA838D87CEC464CA5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_C609A28A40B058378DE5188C004E8C3C" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_EntityCurrentReportingStatus_C609A28A40B058378DE5188C004E8C3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_E3396CF64E1E52A1972920D35AEF392D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_EntityFilerCategory_E3396CF64E1E52A1972920D35AEF392D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_32174223941B5B32B04852D1B307CCC8" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_DocumentEntityInformationAbstract_D3A3EF8331695533BB878974C02EE361" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_32174223941B5B32B04852D1B307CCC8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_46B2B6583E6850949B111C6294EF8E1B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_10FFE969F5CB533DB0CCC0890108059C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46B2B6583E6850949B111C6294EF8E1B" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_10FFE969F5CB533DB0CCC0890108059C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0E366F60CA7190E998709B463067C1AD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0E366F60CA7190E998709B463067C1AD" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_42BBC41FF652DFAC0DBD9B4630689C46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_42BBC41FF652DFAC0DBD9B4630689C46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_F97C0A4ED6A1274514719B463068702C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_F97C0A4ED6A1274514719B463068702C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_74E87A022FF20285922F9B4630681C55" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_74E87A022FF20285922F9B4630681C55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_96E3718FF8D787647F469B46306968DC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_96E3718FF8D787647F469B46306968DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_BDEEB2E93A7EAB2A7D749B4630691C95" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_17322B45013E297C5ACB9B6B0C33C7CB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_BDEEB2E93A7EAB2A7D749B4630691C95" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsEffectOfRiskManagementInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_EE672C6BDE393721F458FE8D9C5859CF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_229C1C59A879E2D00B71FE8D9C593D37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_EE672C6BDE393721F458FE8D9C5859CF" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_229C1C59A879E2D00B71FE8D9C593D37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65850AE3370B3BD8BAB1FE8D9C59A0F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_229C1C59A879E2D00B71FE8D9C593D37" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65850AE3370B3BD8BAB1FE8D9C59A0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_E5D4AB6252BC8B6594F7FE8D9C598AC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65850AE3370B3BD8BAB1FE8D9C59A0F5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_E5D4AB6252BC8B6594F7FE8D9C598AC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetInvestmentHedgingMember" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_D43BB8ACC6896043899BFE8D9C591C88" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_E5D4AB6252BC8B6594F7FE8D9C598AC4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_D43BB8ACC6896043899BFE8D9C591C88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_1E1FB72C4DB824E36C4EFE8D9C597801" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_229C1C59A879E2D00B71FE8D9C593D37" xlink:to="loc_us-gaap_HedgingDesignationAxis_1E1FB72C4DB824E36C4EFE8D9C597801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_065B9757D530DCB00416FE8D9C59B9D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1E1FB72C4DB824E36C4EFE8D9C597801" xlink:to="loc_us-gaap_HedgingDesignationDomain_065B9757D530DCB00416FE8D9C59B9D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0580A28558D61E1D228CFE8D9C597ED8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_065B9757D530DCB00416FE8D9C59B9D2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0580A28558D61E1D228CFE8D9C597ED8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_81BAF1771A42E207FD37FE8D9C59A3E8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_065B9757D530DCB00416FE8D9C59B9D2" xlink:to="loc_us-gaap_NondesignatedMember_81BAF1771A42E207FD37FE8D9C59A3E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_CEBCBBC437D43DDB73BAFE8D9C5907E9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_229C1C59A879E2D00B71FE8D9C593D37" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_CEBCBBC437D43DDB73BAFE8D9C5907E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_F0285492016E00FF457EFE8D9C5ED294" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_CEBCBBC437D43DDB73BAFE8D9C5907E9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_F0285492016E00FF457EFE8D9C5ED294" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HedgedFixedRateDebtMember" xlink:label="loc_lly_HedgedFixedRateDebtMember_FA4A262701FC803A0FF5FE8D9C5E19DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_F0285492016E00FF457EFE8D9C5ED294" xlink:to="loc_lly_HedgedFixedRateDebtMember_FA4A262701FC803A0FF5FE8D9C5E19DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaap_InterestRateContractMember_C485197857F840383D87FE8D9C5FEBA9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_F0285492016E00FF457EFE8D9C5ED294" xlink:to="loc_us-gaap_InterestRateContractMember_C485197857F840383D87FE8D9C5FEBA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6C7CC9AED4F61FEA8915FE8D9C5F8D48" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_F0285492016E00FF457EFE8D9C5ED294" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6C7CC9AED4F61FEA8915FE8D9C5F8D48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_44314C22866A8A440D78FE8D9C5E2033" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_F0285492016E00FF457EFE8D9C5ED294" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_44314C22866A8A440D78FE8D9C5E2033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_229C1C59A879E2D00B71FE8D9C593D37" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_88BD0A1DC017274E1EB9FE8D9C5F83BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_88BD0A1DC017274E1EB9FE8D9C5F83BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_7B184A2806F96FE41D4AFE8D9C5F1812" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_7B184A2806F96FE41D4AFE8D9C5F1812" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_01A30EA6BBCF42A735F6FE8D9C5F6392" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_01A30EA6BBCF42A735F6FE8D9C5F6392" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_2CDAA01A4EE9E6EE2AFAFE8D9C5FEFB9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_2CDAA01A4EE9E6EE2AFAFE8D9C5FEFB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_238BA7C95539C7CF7D45FE8D9C6025F1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B8E89BED0701AC04760CFE8D9C5F93AC" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_238BA7C95539C7CF7D45FE8D9C6025F1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_CDD4DD2B4624A48688FD0390320D4D71" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_380203EA7241B94A6E830390320D1375" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_CDD4DD2B4624A48688FD0390320D4D71" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_380203EA7241B94A6E830390320D1375" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_250AB9C06C933AB1C8940390320DF77B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_380203EA7241B94A6E830390320D1375" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_250AB9C06C933AB1C8940390320DF77B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_250AB9C06C933AB1C8940390320DF77B" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1493E7605D15882518950390320D9E21" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1493E7605D15882518950390320D9E21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_968FA6588D2A6D05595D03903217EB51" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_968FA6588D2A6D05595D03903217EB51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_A921959BD8A0D7523F3203903217D84E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_A921959BD8A0D7523F3203903217D84E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_26AF69129B181EEE56BB039032173BA1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_26AF69129B181EEE56BB039032173BA1" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherEquitySecuritiesMember" xlink:label="loc_lly_OtherEquitySecuritiesMember_ED8CB67D2423F922592C039032177CC8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_lly_OtherEquitySecuritiesMember_ED8CB67D2423F922592C039032177CC8" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_MarketableSecuritiesMember" xlink:label="loc_lly_MarketableSecuritiesMember_21BA37E4A64BA12138D4039032179BDF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_lly_MarketableSecuritiesMember_21BA37E4A64BA12138D4039032179BDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherDebtSecuritiesMember" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_81F89DE28D16ED88501A03903217702D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_81F89DE28D16ED88501A03903217702D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_772FB9D9A1655ADE89BB03903217B92C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_us-gaap_EquitySecuritiesMember_772FB9D9A1655ADE89BB03903217B92C" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EquityMethodAndOtherInvestmentsMember" xlink:label="loc_lly_EquityMethodAndOtherInvestmentsMember_3B6D2B3F76D1B13F63F0039032174460" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_70C8C578ED3ADBD9B2EF0390320D0609" xlink:to="loc_lly_EquityMethodAndOtherInvestmentsMember_3B6D2B3F76D1B13F63F0039032174460" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_A0745038E69926EC8E8D03903217C6B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_380203EA7241B94A6E830390320D1375" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_A0745038E69926EC8E8D03903217C6B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_BB55CF159D73A834667C03903217ACC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_A0745038E69926EC8E8D03903217C6B1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_BB55CF159D73A834667C03903217ACC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_56205BC647BE0DD3C701039032177ECC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_BB55CF159D73A834667C03903217ACC2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_56205BC647BE0DD3C701039032177ECC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_EB7E4E04EC735A241E7A0390321726B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_56205BC647BE0DD3C701039032177ECC" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_EB7E4E04EC735A241E7A0390321726B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7609DDC6ADE7EA17E7FE0390321725D7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_56205BC647BE0DD3C701039032177ECC" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7609DDC6ADE7EA17E7FE0390321725D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_59CDC82F2D6D3758DD1603903217809D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_56205BC647BE0DD3C701039032177ECC" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_59CDC82F2D6D3758DD1603903217809D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4B4E407EFE257FFB6E04039032171DF9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_380203EA7241B94A6E830390320D1375" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4B4E407EFE257FFB6E04039032171DF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FD853407645AEE13BC5403903217C1C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4B4E407EFE257FFB6E04039032171DF9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FD853407645AEE13BC5403903217C1C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_756187B2083208F0DC36039032172830" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FD853407645AEE13BC5403903217C1C3" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_756187B2083208F0DC36039032172830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5BD65E667A1C55C868D2039032170894" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FD853407645AEE13BC5403903217C1C3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5BD65E667A1C55C868D2039032170894" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6B13C2DD52DF72CDE94E039032178668" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_FD853407645AEE13BC5403903217C1C3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6B13C2DD52DF72CDE94E039032178668" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_380203EA7241B94A6E830390320D1375" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0A6EF81E259C1E0CB22403903217CCD7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0A6EF81E259C1E0CB22403903217CCD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_E12E8DD6BC7C5101A6310390321785A5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_E12E8DD6BC7C5101A6310390321785A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesCurrent_B6A87005801E95379434039032170FB3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesCurrent_B6A87005801E95379434039032170FB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_C761F795499AAA19FE3A039032175BB2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_C761F795499AAA19FE3A039032175BB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_C62B3D49067F1F7859E80390321722E9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_C62B3D49067F1F7859E80390321722E9" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EquitySecuritiesFVNI" xlink:label="loc_lly_EquitySecuritiesFVNI_9DA1C50EBE06FB527B7203903217BA47" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_lly_EquitySecuritiesFVNI_9DA1C50EBE06FB527B7203903217BA47" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EquitySecuritieswithoutReadilyDeterminableFairValueAmount" xlink:label="loc_lly_EquitySecuritieswithoutReadilyDeterminableFairValueAmount_59530D5DE48F7D03041F03903217E9EA" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_lly_EquitySecuritieswithoutReadilyDeterminableFairValueAmount_59530D5DE48F7D03041F03903217E9EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLongTermInvestments" xlink:label="loc_us-gaap_OtherLongTermInvestments_097F5E4A3C61C65DEDB3039032177626" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_OtherLongTermInvestments_097F5E4A3C61C65DEDB3039032177626" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaap_LongTermInvestments_5DF42A3B60D7BA72F9B103903217E042" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_LongTermInvestments_5DF42A3B60D7BA72F9B103903217E042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaap_CommercialPaper_D133F3F48EDBA39B420A03903217AE75" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_CommercialPaper_D133F3F48EDBA39B420A03903217AE75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_89ECD027FD10422CA664039032176649" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_02E78DFA42DE9981C54203903217C639" xlink:to="loc_us-gaap_LongTermDebt_89ECD027FD10422CA664039032176649" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7559E44F1E3FC9DD5235FE8D9BE54D9B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2A232E6D708E588696F0FE8D9BEBBEE7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7559E44F1E3FC9DD5235FE8D9BE54D9B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2A232E6D708E588696F0FE8D9BEBBEE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_30D3C280B3C734BB8690FE8D9BEB6DC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2A232E6D708E588696F0FE8D9BEBBEE7" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_30D3C280B3C734BB8690FE8D9BEB6DC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_53BF45BA7E509DB35D3FFE8D9BEB164A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_30D3C280B3C734BB8690FE8D9BEB6DC9" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_53BF45BA7E509DB35D3FFE8D9BEB164A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_55BBE67FA2F8A904E931FE8D9BEB3D28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_53BF45BA7E509DB35D3FFE8D9BEB164A" xlink:to="loc_us-gaap_EquitySecuritiesMember_55BBE67FA2F8A904E931FE8D9BEB3D28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4EE4CA5F995FC318FD6BFE8D9BEBB960" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2A232E6D708E588696F0FE8D9BEBBEE7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4EE4CA5F995FC318FD6BFE8D9BEBB960" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99241CF8C73B19E2632BFE8D9BEC24E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4EE4CA5F995FC318FD6BFE8D9BEBB960" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99241CF8C73B19E2632BFE8D9BEC24E4" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ForeignCurrencyDenominatedDebtMember" xlink:label="loc_lly_ForeignCurrencyDenominatedDebtMember_4DB2EB605E4B23F6F225FE8D9BECA0E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99241CF8C73B19E2632BFE8D9BEC24E4" xlink:to="loc_lly_ForeignCurrencyDenominatedDebtMember_4DB2EB605E4B23F6F225FE8D9BECA0E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7206CC31206D677E48A5FE8D9BEC016E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2A232E6D708E588696F0FE8D9BEBBEE7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7206CC31206D677E48A5FE8D9BEC016E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7206CC31206D677E48A5FE8D9BEC016E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BuyUsDollarSellEuroMember" xlink:label="loc_lly_BuyUsDollarSellEuroMember_D1FACA3E700B7E1F9186FE8D9BEC8D26" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:to="loc_lly_BuyUsDollarSellEuroMember_D1FACA3E700B7E1F9186FE8D9BEC8D26" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BuyEuroSellUsDollarMember" xlink:label="loc_lly_BuyEuroSellUsDollarMember_19344F24D6F86107FF1AFE8D9BEC8B05" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:to="loc_lly_BuyEuroSellUsDollarMember_19344F24D6F86107FF1AFE8D9BEC8B05" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BuyUSdollarSellJapaneseYenMember" xlink:label="loc_lly_BuyUSdollarSellJapaneseYenMember_619EF44695F1716142E0FE8D9BEC6BCE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:to="loc_lly_BuyUSdollarSellJapaneseYenMember_619EF44695F1716142E0FE8D9BEC6BCE" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BuyGBPSellUSDMember" xlink:label="loc_lly_BuyGBPSellUSDMember_C3AD3391F2E2DCC2867BFE8D9BECB06D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:to="loc_lly_BuyGBPSellUSDMember_C3AD3391F2E2DCC2867BFE8D9BECB06D" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BuyUSdollarSellBritishpoundMember" xlink:label="loc_lly_BuyUSdollarSellBritishpoundMember_0BE0466D9D7353A6CE63FE8D9BECEC88" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_259189B8DEA7A0E7BD80FE8D9BEC8977" xlink:to="loc_lly_BuyUSdollarSellBritishpoundMember_0BE0466D9D7353A6CE63FE8D9BECEC88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2A232E6D708E588696F0FE8D9BEBBEE7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_50AC811C22E77BA950BAFE8D9BEC35DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_50AC811C22E77BA950BAFE8D9BEC35DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_428453BE3A3E937170BEFE8D9BECF3F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_428453BE3A3E937170BEFE8D9BECF3F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_4257568E899FF9364553FE8D9BEDBDF1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_4257568E899FF9364553FE8D9BEDBDF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_C126EF4BC0914C1A89F3FE8D9BEDC6C8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_LongTermDebt_C126EF4BC0914C1A89F3FE8D9BEDC6C8" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_DescriptionOfDerivativeActivityVolumePercent" xlink:label="loc_lly_DescriptionOfDerivativeActivityVolumePercent_12A78BC6D281478B49E0FE8D9BED4E9E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_lly_DescriptionOfDerivativeActivityVolumePercent_12A78BC6D281478B49E0FE8D9BED4E9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_83E8C90F157E1991BF0BFE8D9BEDAED6" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_83E8C90F157E1991BF0BFE8D9BEDAED6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9D6A73D20AD91687125CFE8D9BEDCF7C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9D6A73D20AD91687125CFE8D9BEDCF7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaap_ImpairmentOfInvestments_775D8CA8A35CF5E66223FE8D9BED5A9E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_ImpairmentOfInvestments_775D8CA8A35CF5E66223FE8D9BED5A9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities_9C7619E05200D63D9CB8FE8D9BED9636" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_UnrealizedGainLossOnSecurities_9C7619E05200D63D9CB8FE8D9BED9636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets_1C2C770E214761C38560FE8D9BED9E1A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets_1C2C770E214761C38560FE8D9BED9E1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_C941CEA5E774A65B8CFEFE8D9BED083F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EC6D21B38C1B3EEE7732FE8D9BECF812" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_C941CEA5E774A65B8CFEFE8D9BED083F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_CE73798709705F48967CEDD300275BBB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_EE97344AB170551F9FF4696A9D75AF4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_CE73798709705F48967CEDD300275BBB" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_EE97344AB170551F9FF4696A9D75AF4C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsRealizedGainAndLossesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2BECEC5B801557B2FCB5039220A502ED" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_8E3CE091083AFE425C2E039220A51970" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2BECEC5B801557B2FCB5039220A502ED" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_8E3CE091083AFE425C2E039220A51970" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGains" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_DE0C87560548FE5ECDAA039220A59D7A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2BECEC5B801557B2FCB5039220A502ED" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGains_DE0C87560548FE5ECDAA039220A59D7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_D39C29FB95F86BD89013039220A58B86" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2BECEC5B801557B2FCB5039220A502ED" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses_D39C29FB95F86BD89013039220A58B86" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AdoptionofASUAbstract" xlink:label="loc_lly_AdoptionofASUAbstract_A308895FB67A1D551F87039220A51C95" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2BECEC5B801557B2FCB5039220A502ED" xlink:to="loc_lly_AdoptionofASUAbstract_A308895FB67A1D551F87039220A51C95" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ProceedsfromSaleofEquityandAvailableforSaleSecurities" xlink:label="loc_lly_ProceedsfromSaleofEquityandAvailableforSaleSecurities_B8702F1059204CDBF0F1039220AF9B4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_AdoptionofASUAbstract_A308895FB67A1D551F87039220A51C95" xlink:to="loc_lly_ProceedsfromSaleofEquityandAvailableforSaleSecurities_B8702F1059204CDBF0F1039220AF9B4D" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain" xlink:label="loc_lly_AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain_0C35DB918048E749C1E5039220AFE974" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_AdoptionofASUAbstract_A308895FB67A1D551F87039220A51C95" xlink:to="loc_lly_AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain_0C35DB918048E749C1E5039220AFE974" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss" xlink:label="loc_lly_AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss_81822349576B48AEAD8F039220AFBE3E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_AdoptionofASUAbstract_A308895FB67A1D551F87039220A51C95" xlink:to="loc_lly_AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss_81822349576B48AEAD8F039220AFBE3E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsRiskManagementInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_C07FA5682720EA7F8855F34A63A1F90B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_C07FA5682720EA7F8855F34A63A1F90B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4B9F5161659F26E0069EF34A63A121E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4B9F5161659F26E0069EF34A63A121E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_98B434A1151F00633B74F34A63A1CF94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4B9F5161659F26E0069EF34A63A121E4" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_98B434A1151F00633B74F34A63A1CF94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_243E0B3533FBB4CD8D3CF34A63A10F8C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_98B434A1151F00633B74F34A63A1CF94" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_243E0B3533FBB4CD8D3CF34A63A10F8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6BC88D6034944774A028F34A63A124A0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_243E0B3533FBB4CD8D3CF34A63A10F8C" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6BC88D6034944774A028F34A63A124A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1D48867FA9DDDBE2CBB0F34A63A12EBA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_243E0B3533FBB4CD8D3CF34A63A10F8C" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1D48867FA9DDDBE2CBB0F34A63A12EBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7ECAD0E73245EFD8D80EF34A63A23F2F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7ECAD0E73245EFD8D80EF34A63A23F2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_AF8C65B82F4613EF389EF34A63A2C0BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7ECAD0E73245EFD8D80EF34A63A23F2F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_AF8C65B82F4613EF389EF34A63A2C0BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaap_InterestRateContractMember_CB1913B8792DC9463417F34A63A23048" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AF8C65B82F4613EF389EF34A63A2C0BB" xlink:to="loc_us-gaap_InterestRateContractMember_CB1913B8792DC9463417F34A63A23048" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_03D2DDA74D56B246B065F34A63A2EB75" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AF8C65B82F4613EF389EF34A63A2C0BB" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_03D2DDA74D56B246B065F34A63A2EB75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_EF473B47EB7AB48117DDF34A63A2CB95" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AF8C65B82F4613EF389EF34A63A2C0BB" xlink:to="loc_us-gaap_ForeignExchangeContractMember_EF473B47EB7AB48117DDF34A63A2CB95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_C461FCEED432DC8D8322F34A63A21DDF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:to="loc_us-gaap_HedgingDesignationAxis_C461FCEED432DC8D8322F34A63A21DDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_03AD2321AC63C6D70A63F34A63A288A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_C461FCEED432DC8D8322F34A63A21DDF" xlink:to="loc_us-gaap_HedgingDesignationDomain_03AD2321AC63C6D70A63F34A63A288A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_92E09BDE468C8912DADCF34A63A20F7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_03AD2321AC63C6D70A63F34A63A288A1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_92E09BDE468C8912DADCF34A63A20F7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_F28C90F8F5E414B671BDF34A63A20CA6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_03AD2321AC63C6D70A63F34A63A288A1" xlink:to="loc_us-gaap_NondesignatedMember_F28C90F8F5E414B671BDF34A63A20CA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_805345D45AD0D2CFA603F34A63A2353A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_805345D45AD0D2CFA603F34A63A2353A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0FAB1CF1E99E74E233AEF34A63A2074D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_805345D45AD0D2CFA603F34A63A2353A" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0FAB1CF1E99E74E233AEF34A63A2074D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9213E250858851D5320EF34A63A20323" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0FAB1CF1E99E74E233AEF34A63A2074D" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9213E250858851D5320EF34A63A20323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_E382CAF7B0DB792136E5F34A63A29FF1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0FAB1CF1E99E74E233AEF34A63A2074D" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_E382CAF7B0DB792136E5F34A63A29FF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_E5A9E89B6B2B630489E2F34A63A2C859" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0FAB1CF1E99E74E233AEF34A63A2074D" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_E5A9E89B6B2B630489E2F34A63A2C859" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_144FCDC42B33E4E701B4F34A63A19A45" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsCurrent" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_27F16E9FEE26D79C92BAF34A63A201FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_27F16E9FEE26D79C92BAF34A63A201FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_CE304B370B8FC5EAA7F7F34A63A3991B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_CE304B370B8FC5EAA7F7F34A63A3991B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_0393B0B3CDBD4D603D14F34A63A37FB8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_0393B0B3CDBD4D603D14F34A63A37FB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_95BC4FD0F3AF6EEE604CF34A63A3CC05" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_95BC4FD0F3AF6EEE604CF34A63A3CC05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_BCC55D6DC4102046E26AF34A63A3552F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_BCC55D6DC4102046E26AF34A63A3552F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9646E25428DD969D18CDF34A63A3627F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F92DF30017094DE05B1DF34A63A2CCA1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9646E25428DD969D18CDF34A63A3627F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_11F1D56E4164D34FD487F099B0F2550E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_11F1D56E4164D34FD487F099B0F2550E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_2F0AB474EA29603DBC23F099B0F29D1B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_2F0AB474EA29603DBC23F099B0F29D1B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_BEC23A8BEE54C81DAE3DF099B0F22151" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_BEC23A8BEE54C81DAE3DF099B0F22151" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_8FFD1C848507C78158A2F099B0F28086" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_8FFD1C848507C78158A2F099B0F28086" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_F3FC5472CB5A4D5CC607F099B0F27BE5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_F3FC5472CB5A4D5CC607F099B0F27BE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_8CFCBE1F3BE8F5D092E4F099B0F277BD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_8CFCBE1F3BE8F5D092E4F099B0F277BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_6BFF801F34ECC73ADF68F099B0F2D276" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_6BFF801F34ECC73ADF68F099B0F2D276" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_9FB9FA9ACA63BB65A1C1F0AC40DA3039" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9F31578530B4838AF8E6F099B0F29A6F" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_9FB9FA9ACA63BB65A1C1F0AC40DA3039" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/FinancialInstrumentsUnrealizedGainAndLossesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_94B4D123FA815C359F0F57AE4E88D1AB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_25A3E7659165517A8530537F89BC8F6B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_94B4D123FA815C359F0F57AE4E88D1AB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_25A3E7659165517A8530537F89BC8F6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BAA39A649A5E5A97B62CB72D72D7D891" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_94B4D123FA815C359F0F57AE4E88D1AB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BAA39A649A5E5A97B62CB72D72D7D891" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue" xlink:label="loc_lly_AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue_9DD861F6A8565BCAB4D745B4D438BF32" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_94B4D123FA815C359F0F57AE4E88D1AB" xlink:to="loc_lly_AvailableForSaleSecuritiesContinuousUnrealizedGainPositionFairValue_9DD861F6A8565BCAB4D745B4D438BF32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_D9B67E05D3E650D79A2F71BF89E16628" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_94B4D123FA815C359F0F57AE4E88D1AB" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_D9B67E05D3E650D79A2F71BF89E16628" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ImplementationOfNewAccountingPronouncementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_F77088E341475312A32B3E7AE26159F7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_E4F6D5C3F61C5E9D91F56220B7A1F12D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_F77088E341475312A32B3E7AE26159F7" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_E4F6D5C3F61C5E9D91F56220B7A1F12D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ImplementationOfNewFinancialAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_B4C74CE3EA5A5295AC188B45BE7C5B0B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_16F26366A6205A58970E9D649F6E7AC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_B4C74CE3EA5A5295AC188B45BE7C5B0B" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_16F26366A6205A58970E9D649F6E7AC9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ImplementationOfNewFinancialAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_B206623C13A7DFF971E0FE8D9CEF6CDA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1E8F24F2CDBB2251BCC0FE8D9CEFEE1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_B206623C13A7DFF971E0FE8D9CEF6CDA" xlink:to="loc_us-gaap_ConcentrationRiskTable_1E8F24F2CDBB2251BCC0FE8D9CEFEE1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_B4E0420BC788F2B88019FE8D9CF0C4DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1E8F24F2CDBB2251BCC0FE8D9CEFEE1E" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_B4E0420BC788F2B88019FE8D9CF0C4DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_FCB84788FDCFDF23E366FE8D9CF07A43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_B4E0420BC788F2B88019FE8D9CF0C4DE" xlink:to="loc_us-gaap_TypeOfAdoptionMember_FCB84788FDCFDF23E366FE8D9CF07A43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_6C3047F1C40A58D148A3FE8D9CF0D1AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_FCB84788FDCFDF23E366FE8D9CF07A43" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_6C3047F1C40A58D148A3FE8D9CF0D1AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingStandardsUpdate201616Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201616Member_DD09C3C905ED723661DBFE8D9CF01A4F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_FCB84788FDCFDF23E366FE8D9CF07A43" xlink:to="loc_us-gaap_AccountingStandardsUpdate201616Member_DD09C3C905ED723661DBFE8D9CF01A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingStandardsUpdate201601Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201601Member_C5329D8BEB201CD6B010FE8D9CF04733" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_FCB84788FDCFDF23E366FE8D9CF07A43" xlink:to="loc_us-gaap_AccountingStandardsUpdate201601Member_C5329D8BEB201CD6B010FE8D9CF04733" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AccountingStandardsUpdate201707Member" xlink:label="loc_lly_AccountingStandardsUpdate201707Member_9F62D8B5F76D6DD16DB2FE8D9CF0B077" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_FCB84788FDCFDF23E366FE8D9CF07A43" xlink:to="loc_lly_AccountingStandardsUpdate201707Member_9F62D8B5F76D6DD16DB2FE8D9CF0B077" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1E8F24F2CDBB2251BCC0FE8D9CEFEE1E" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8B87ADEDE32ADD9BA1C3FE8D9CF0A8C2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8B87ADEDE32ADD9BA1C3FE8D9CF0A8C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E2AE3228A98D5232B686FE8D9CF03957" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E2AE3228A98D5232B686FE8D9CF03957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1CAFB873BF17FB38B2C5FE8D9CF0CC2B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_Revenues_1CAFB873BF17FB38B2C5FE8D9CF0CC2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_D3DAB84E56E4AC7A52ACFE8D9CF06C9A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_D3DAB84E56E4AC7A52ACFE8D9CF06C9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_FF0815E2BF2B7194E52AFE8D9CF0342F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_FF0815E2BF2B7194E52AFE8D9CF0342F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_568EFB64591A5311CD69FE8D9CF02358" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_CostOfGoodsSold_568EFB64591A5311CD69FE8D9CF02358" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_BEBC85480DE4332A36DEFE8D9CF15295" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_BEBC85480DE4332A36DEFE8D9CF15295" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7AC758061D7C5CA176C3FE8D9CF12DA2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_8A3A9DF15550077390FCFE8D9CF00EE4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7AC758061D7C5CA176C3FE8D9CF12DA2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_51E73E6EB684505685F1C2A2B16C8A93" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_975F3D6618195A968C82402E4F798698" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51E73E6EB684505685F1C2A2B16C8A93" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_975F3D6618195A968C82402E4F798698" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_51397E5FC7A1F77A07DBF099B08E4DC0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_C11CA982CE21FA17838DF099B08E7E4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51397E5FC7A1F77A07DBF099B08E4DC0" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_C11CA982CE21FA17838DF099B08E7E4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_0579E672F6CDB4E95966F099B08E24BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_C11CA982CE21FA17838DF099B08E7E4C" xlink:to="loc_us-gaap_TaxPeriodAxis_0579E672F6CDB4E95966F099B08E24BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_3425F375DD17EC87C001F099B08EC824" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_0579E672F6CDB4E95966F099B08E24BD" xlink:to="loc_us-gaap_TaxPeriodDomain_3425F375DD17EC87C001F099B08EC824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxYear2013Member" xlink:label="loc_us-gaap_TaxYear2013Member_32BAC9B4EDC27A68D27FF099B08F0C20" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_3425F375DD17EC87C001F099B08EC824" xlink:to="loc_us-gaap_TaxYear2013Member_32BAC9B4EDC27A68D27FF099B08F0C20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxYear2014Member" xlink:label="loc_us-gaap_TaxYear2014Member_329C24D23F6AFA1BE9E9F099B08F3DCB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_3425F375DD17EC87C001F099B08EC824" xlink:to="loc_us-gaap_TaxYear2014Member_329C24D23F6AFA1BE9E9F099B08F3DCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxYear2015Member" xlink:label="loc_us-gaap_TaxYear2015Member_6EE0FA94B1B180D8FA5CF099B08FFA90" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_3425F375DD17EC87C001F099B08EC824" xlink:to="loc_us-gaap_TaxYear2015Member_6EE0FA94B1B180D8FA5CF099B08FFA90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_235760FD8FCB92190703F099B08F35F8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_C11CA982CE21FA17838DF099B08E7E4C" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_235760FD8FCB92190703F099B08F35F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_05665C0B969FB679758DF099B08FC79E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_235760FD8FCB92190703F099B08F35F8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_05665C0B969FB679758DF099B08FC79E" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CoLucidPharmaceuticalsMember" xlink:label="loc_lly_CoLucidPharmaceuticalsMember_A893ACA08547991E7E47F099B08F00BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_05665C0B969FB679758DF099B08FC79E" xlink:to="loc_lly_CoLucidPharmaceuticalsMember_A893ACA08547991E7E47F099B08F00BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_298DA5C9545892241CF1F099B08FC394" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_C11CA982CE21FA17838DF099B08E7E4C" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_298DA5C9545892241CF1F099B08FC394" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3858896F16310FFFC018F0BE6C5320EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_298DA5C9545892241CF1F099B08FC394" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3858896F16310FFFC018F0BE6C5320EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_B192B6DC0327F3D59935F0BE6CC929A4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_298DA5C9545892241CF1F099B08FC394" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_B192B6DC0327F3D59935F0BE6CC929A4" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquiredInProcessResearchAndDevelopment" xlink:label="loc_lly_AcquiredInProcessResearchAndDevelopment_9A85E53789E7ACBEF3FEF099B08F4839" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_298DA5C9545892241CF1F099B08FC394" xlink:to="loc_lly_AcquiredInProcessResearchAndDevelopment_9A85E53789E7ACBEF3FEF099B08F4839" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_B92B6A5E138F2738F8D8F099B08F811A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_298DA5C9545892241CF1F099B08FC394" xlink:to="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_B92B6A5E138F2738F8D8F099B08F811A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_E3D3CD01427556C8B1FA8D600DA9DCD3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_554DC491B97059ACBD1653D1B6E6217F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_E3D3CD01427556C8B1FA8D600DA9DCD3" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_554DC491B97059ACBD1653D1B6E6217F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherComprehensiveIncomeLossAociDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_565F1D643AECA4D6223B033C3EA66F0A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_DE95D140805490A339BC033C3EA7B360" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_565F1D643AECA4D6223B033C3EA66F0A" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_DE95D140805490A339BC033C3EA7B360" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3408C7246957EDC45936033C3EA790EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_DE95D140805490A339BC033C3EA7B360" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3408C7246957EDC45936033C3EA790EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F339DF870BA8B59ED348033C3EA7C273" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3408C7246957EDC45936033C3EA790EE" xlink:to="loc_us-gaap_EquityComponentDomain_F339DF870BA8B59ED348033C3EA7C273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F339DF870BA8B59ED348033C3EA7C273" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9ED238BF2B1E1CB2682C033C3EA7F1CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9ED238BF2B1E1CB2682C033C3EA7F1CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_92065E4B195D80A5050A033C3EA70F2E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_92065E4B195D80A5050A033C3EA70F2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_6A745A7FFFA61F45CEF0033C3EA714BD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_6A745A7FFFA61F45CEF0033C3EA714BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_0AA962CC6534D8899CBA033C3EAD084F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_0AA962CC6534D8899CBA033C3EAD084F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_949B431C50DFA22D7952033C3EADFE37" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_949B431C50DFA22D7952033C3EADFE37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AociAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociAttributableToNoncontrollingInterestMember_450853B431371B139B7E033C3EAD9D8A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_429CA02F27374EEBFACA033C3EA7FFFF" xlink:to="loc_us-gaap_AociAttributableToNoncontrollingInterestMember_450853B431371B139B7E033C3EAD9D8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_E48662DFD4EDCE75B1DE033C3EAD9B87" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_DE95D140805490A339BC033C3EA7B360" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_E48662DFD4EDCE75B1DE033C3EAD9B87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_E48662DFD4EDCE75B1DE033C3EAD9B87" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_DC6CDAEEC978CAFA3D39033C3EADF4C2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_DC6CDAEEC978CAFA3D39033C3EADF4C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_21334C1C50D43A9ECB05033C3EADBC7D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_21334C1C50D43A9ECB05033C3EADBC7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D612695316E69402DF42033C3EAD5303" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D612695316E69402DF42033C3EAD5303" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_A94F53F7581FA041BF48033C3EAEB7CB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_A94F53F7581FA041BF48033C3EAEB7CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_F2C7CE09ED72C5C0D3AD033C3EAE3FAB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_F2C7CE09ED72C5C0D3AD033C3EAE3FAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A28B3BA634485421A98033C3EAE76D5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ADC253D171BF375DC49D033C3EAD5EEC" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A28B3BA634485421A98033C3EAE76D5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherComprehensiveIncomeLossReclassificationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_39D2E58B6399A84558770709CE7466D7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2F6BA78E294FA8E1FC450709CE74CDEE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_39D2E58B6399A84558770709CE7466D7" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2F6BA78E294FA8E1FC450709CE74CDEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_B44974DC9126F32E3F230709CE746E0C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2F6BA78E294FA8E1FC450709CE74CDEE" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_B44974DC9126F32E3F230709CE746E0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B44974DC9126F32E3F230709CE746E0C" xlink:to="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember_8F3C8888913680E406620709CE747080" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember_8F3C8888913680E406620709CE747080" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_C43F404847F1D5ACA53C0709CE74B931" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_C43F404847F1D5ACA53C0709CE74B931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_A107594AA8F0F883A1D80709CE748CF9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_A107594AA8F0F883A1D80709CE748CF9" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AccumulatedNetGainLossfromCashFlowHedgesandForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:label="loc_lly_AccumulatedNetGainLossfromCashFlowHedgesandForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_996274615291DBA612520709CE74047B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:to="loc_lly_AccumulatedNetGainLossfromCashFlowHedgesandForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_996274615291DBA612520709CE74047B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_5C3E4C66304B385912220709CE746D3E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25A5B0E652130051E89F0709CE7485CD" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_5C3E4C66304B385912220709CE746D3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_08C8F2AFC39D99B7DBFD0709CE747EF3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2F6BA78E294FA8E1FC450709CE74CDEE" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_08C8F2AFC39D99B7DBFD0709CE747EF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_345D38B02EF254DF84870709CE745DC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_08C8F2AFC39D99B7DBFD0709CE747EF3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_345D38B02EF254DF84870709CE745DC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_21FE7E993EB10C707F8D0709CE742D0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_345D38B02EF254DF84870709CE745DC4" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_21FE7E993EB10C707F8D0709CE742D0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2F6BA78E294FA8E1FC450709CE74CDEE" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_723B44CDDDAD308DD82B0709CE757B75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_723B44CDDDAD308DD82B0709CE757B75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_E3B5C19CF8EADF97BC690709CE7577AB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_E3B5C19CF8EADF97BC690709CE7577AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8A94460BA39C07A6C7B50709CE75E176" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8A94460BA39C07A6C7B50709CE75E176" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_49EA1BF06FC5F4BE120A0709CE75484A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_49EA1BF06FC5F4BE120A0709CE75484A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_42E144C74ED5C5029F5F0709CE755B5E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_42E144C74ED5C5029F5F0709CE755B5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7F9146992B47EAD4FC020709CE75F8A2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_E9032450453F7B44842F0709CE74E5C3" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7F9146992B47EAD4FC020709CE75F8A2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_45000408E1DE5F7EBF3D558CC1B9AD9A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_FBEF783C8F7B54A89EA4551DF6F97CC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_45000408E1DE5F7EBF3D558CC1B9AD9A" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_FBEF783C8F7B54A89EA4551DF6F97CC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_38A5B3B18121519A9C34D469E782B708" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_45000408E1DE5F7EBF3D558CC1B9AD9A" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_38A5B3B18121519A9C34D469E782B708" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherComprehensiveIncomeLossTaxEffectDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_013F23B60B391868BB8FFE8D9B463877" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_67A9A6B00EBC4D15544DFE8D9B46E2BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_013F23B60B391868BB8FFE8D9B463877" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_67A9A6B00EBC4D15544DFE8D9B46E2BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36F1EDA1FDE2F8736FC8FE8D9B46B2BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_67A9A6B00EBC4D15544DFE8D9B46E2BA" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36F1EDA1FDE2F8736FC8FE8D9B46B2BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F7B40D2A13456ECB902EFE8D9B46AA14" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36F1EDA1FDE2F8736FC8FE8D9B46B2BC" xlink:to="loc_us-gaap_EquityComponentDomain_F7B40D2A13456ECB902EFE8D9B46AA14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_58A39B3D7C758618EDA6FE8D9B46EAEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F7B40D2A13456ECB902EFE8D9B46AA14" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_58A39B3D7C758618EDA6FE8D9B46EAEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_61E8BC0FACF3A746A75AFE8D9B47C6AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F7B40D2A13456ECB902EFE8D9B46AA14" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_61E8BC0FACF3A746A75AFE8D9B47C6AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_BAFB0E36062DBFE59688FE8D9B475A20" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F7B40D2A13456ECB902EFE8D9B46AA14" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_BAFB0E36062DBFE59688FE8D9B475A20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_E72FAE053B18A2ED245DFE8D9B4797F0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F7B40D2A13456ECB902EFE8D9B46AA14" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_E72FAE053B18A2ED245DFE8D9B4797F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_EC4944A5630D7093BF07FE8D9B478A70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_67A9A6B00EBC4D15544DFE8D9B46E2BA" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_EC4944A5630D7093BF07FE8D9B478A70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_A13C3D56A2C26C49184EFE8D9B47D232" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_EC4944A5630D7093BF07FE8D9B478A70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_A13C3D56A2C26C49184EFE8D9B47D232" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherNetIncomeExpense" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_F387FD2659125D8E91DD87348BB08C07" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_F26FCEC014D05471AAFD0803DF32B2CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_F387FD2659125D8E91DD87348BB08C07" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_F26FCEC014D05471AAFD0803DF32B2CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherNetIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_DF43836F66997C535332FFAED0FF1097" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_C028B32BB0BC2B884296FFAED1019BD0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_DF43836F66997C535332FFAED0FF1097" xlink:to="loc_us-gaap_InterestExpense_C028B32BB0BC2B884296FFAED1019BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_F31547BF6AC372705E69FFAED10446EF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_DF43836F66997C535332FFAED0FF1097" xlink:to="loc_us-gaap_InvestmentIncomeInterest_F31547BF6AC372705E69FFAED10446EF" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponent" xlink:label="loc_lly_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponent_FA79118BE11AABE92CAEFFAFC5859963" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_DF43836F66997C535332FFAED0FF1097" xlink:to="loc_lly_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponent_FA79118BE11AABE92CAEFFAFC5859963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_290C58F7BB8F20587707FFAED104921B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_DF43836F66997C535332FFAED0FF1097" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_290C58F7BB8F20587707FFAED104921B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_836645E3683FAB43DBFEFFAED10493E8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_DF43836F66997C535332FFAED0FF1097" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_836645E3683FAB43DBFEFFAED10493E8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/OtherNetIncomeExpenseTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_BA5C56E87F5054DCDA12D1DC0D09EA4D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_F6AD51044075EAEB5D69D1DC0D094019" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_BA5C56E87F5054DCDA12D1DC0D09EA4D" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_F6AD51044075EAEB5D69D1DC0D094019" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/RetirementBenefits" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_F43E8A483F525039AB86F25D41E66D30" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_52452314C4B054719A2BD71D2B8100CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_F43E8A483F525039AB86F25D41E66D30" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_52452314C4B054719A2BD71D2B8100CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/RetirementBenefitsComponentsOfNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0E6DFA4D2FA195781120FE8D9B922EB6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_04CDD32A523F03A2276BFE8D9B92DF0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0E6DFA4D2FA195781120FE8D9B922EB6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_04CDD32A523F03A2276BFE8D9B92DF0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetirementPlanTypeAxis" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_469C01B3C342E09E96DDFE8D9B9239D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_04CDD32A523F03A2276BFE8D9B92DF0D" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_469C01B3C342E09E96DDFE8D9B9239D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetirementPlanTypeDomain" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_09AFB34A62964611F140FE8D9B9241F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_469C01B3C342E09E96DDFE8D9B9239D2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_09AFB34A62964611F140FE8D9B9241F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4727E07C73590C460CA4FE8D9B927BBB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_09AFB34A62964611F140FE8D9B9241F4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4727E07C73590C460CA4FE8D9B927BBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8C74BF53F731244D59AEFE8D9B93B24A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_09AFB34A62964611F140FE8D9B9241F4" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8C74BF53F731244D59AEFE8D9B93B24A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_04CDD32A523F03A2276BFE8D9B92DF0D" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_224E43FD5455499E0806FE8D9B93A810" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_224E43FD5455499E0806FE8D9B93A810" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_73D9C0B5DA690B7D1116FE8D9B933913" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_73D9C0B5DA690B7D1116FE8D9B933913" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_96236F34C7CAC669CCCBFE8D9B93FB8A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_96236F34C7CAC669CCCBFE8D9B93FB8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_F0DA9D0B055ED9EDB188FE8D9B93679C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_F0DA9D0B055ED9EDB188FE8D9B93679C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_EBDEB238AE3326918B5DFE8D9B9399FA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_EBDEB238AE3326918B5DFE8D9B9399FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1FB57065DC2DA0FC285AFE8D9B93D6AA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_075B090C26ADC053EF09FE8D9B93C4DF" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1FB57065DC2DA0FC285AFE8D9B93D6AA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/RetirementBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_0DECCDCB0B9C06DD3914D1DC0DDDF496" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionContributions" xlink:label="loc_us-gaap_PensionContributions_C6526F80AB93241AF101D1DC0DE0F655" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_0DECCDCB0B9C06DD3914D1DC0DDDF496" xlink:to="loc_us-gaap_PensionContributions_C6526F80AB93241AF101D1DC0DE0F655" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_D0B94342C43E83F9FEF0D1DC0DE0C0FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_0DECCDCB0B9C06DD3914D1DC0DDDF496" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_D0B94342C43E83F9FEF0D1DC0DE0C0FE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/RetirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_9FBBD8FD553C3574DD2B72B00F0BED9B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_167512D9667EA135022D72B00F0B2068" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_9FBBD8FD553C3574DD2B72B00F0BED9B" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_167512D9667EA135022D72B00F0B2068" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetirementPlanTypeAxis" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ABE9DCBC9ED606252FB772B00F0CB477" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_167512D9667EA135022D72B00F0B2068" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ABE9DCBC9ED606252FB772B00F0CB477" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetirementPlanTypeDomain" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_E2B22E12E09362F6EA4272B00F0CDB10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ABE9DCBC9ED606252FB772B00F0CB477" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_E2B22E12E09362F6EA4272B00F0CDB10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6AAE388D18A5E242EB4F72B00F0CE833" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_E2B22E12E09362F6EA4272B00F0CDB10" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6AAE388D18A5E242EB4F72B00F0CE833" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_61AA087C786A11F7DA6C72B00F0CC749" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_E2B22E12E09362F6EA4272B00F0CDB10" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_61AA087C786A11F7DA6C72B00F0CC749" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_10C0F53887268F21B92672B420DF48CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_167512D9667EA135022D72B00F0B2068" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_10C0F53887268F21B92672B420DF48CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2E5B9B276D83AB86DED672B00F0C452A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_10C0F53887268F21B92672B420DF48CB" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2E5B9B276D83AB86DED672B00F0C452A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_CD2B8F8BAC265D4A9D01126284A64907" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_CAA93771B2A950DA9F5015D7A94514AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_CD2B8F8BAC265D4A9D01126284A64907" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_CAA93771B2A950DA9F5015D7A94514AE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_E311B6F760F5FBF8B8D1D1DC0C7DC076" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_D92322A09C37D7D9E9D2D1DC0C821E01" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_E311B6F760F5FBF8B8D1D1DC0C7DC076" xlink:to="loc_us-gaap_NumberOfOperatingSegments_D92322A09C37D7D9E9D2D1DC0C821E01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7751F012274AD486DA85D1DC0C7D103B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_E311B6F760F5FBF8B8D1D1DC0C7DC076" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7751F012274AD486DA85D1DC0C7D103B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_6557D7FD804DA792CD49D1DC0C7D4907" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7751F012274AD486DA85D1DC0C7D103B" xlink:to="loc_us-gaap_ProductOrServiceAxis_6557D7FD804DA792CD49D1DC0C7D4907" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_F37F580F2020ADB15919D1DC0C7DE813" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_6557D7FD804DA792CD49D1DC0C7D4907" xlink:to="loc_us-gaap_ProductsAndServicesDomain_F37F580F2020ADB15919D1DC0C7DE813" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CymbaltaMember" xlink:label="loc_lly_CymbaltaMember_E283FCDA1A2761BC4C2AD1DC0C7D1095" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_F37F580F2020ADB15919D1DC0C7DE813" xlink:to="loc_lly_CymbaltaMember_E283FCDA1A2761BC4C2AD1DC0C7D1095" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_68B24BE4A6209D27A33DD1DC0C820C07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7751F012274AD486DA85D1DC0C7D103B" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_68B24BE4A6209D27A33DD1DC0C820C07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_71FBF6C2D9DFA8CF53C0D1DC0C82FED6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_68B24BE4A6209D27A33DD1DC0C820C07" xlink:to="loc_us-gaap_SegmentDomain_71FBF6C2D9DFA8CF53C0D1DC0C82FED6" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumanPharmaceuticalProductsMember" xlink:label="loc_lly_HumanPharmaceuticalProductsMember_1CD83BADC28CA71AF4DDD1DC0C822E3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_71FBF6C2D9DFA8CF53C0D1DC0C82FED6" xlink:to="loc_lly_HumanPharmaceuticalProductsMember_1CD83BADC28CA71AF4DDD1DC0C822E3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0F47D4E74086B2AB9035D1DC0C8221CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7751F012274AD486DA85D1DC0C7D103B" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0F47D4E74086B2AB9035D1DC0C8221CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_D64DB5AEEC71605833BCD1DC0C82F468" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0F47D4E74086B2AB9035D1DC0C8221CD" xlink:to="loc_us-gaap_Revenues_D64DB5AEEC71605833BCD1DC0C82F468" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/SegmentInformationRevenueByProductDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_50A545172CC94E1C0661FE8D9B30A37B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_107986D68E0D763C5D55FE8D9B304006" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_50A545172CC94E1C0661FE8D9B30A37B" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_107986D68E0D763C5D55FE8D9B304006" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_973101C207ADEF136455FE8D9B303B4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_107986D68E0D763C5D55FE8D9B304006" xlink:to="loc_us-gaap_StatementGeographicalAxis_973101C207ADEF136455FE8D9B303B4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_973101C207ADEF136455FE8D9B303B4D" xlink:to="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_F8662D701668EB569A68FE8D9B306D72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:to="loc_country_US_F8662D701668EB569A68FE8D9B306D72" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_InternationalMember" xlink:label="loc_lly_InternationalMember_76683BCC0C6CDEBBCA7DFE8D9B30B30B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:to="loc_lly_InternationalMember_76683BCC0C6CDEBBCA7DFE8D9B30B30B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EuropeMember" xlink:label="loc_us-gaap_EuropeMember_B1A69B6E8FDE364DAF2AFE8D9B304966" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:to="loc_us-gaap_EuropeMember_B1A69B6E8FDE364DAF2AFE8D9B304966" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="loc_country_JP_0428F1B4FCBA5FAD4C20FE8D9B30700E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:to="loc_country_JP_0428F1B4FCBA5FAD4C20FE8D9B30700E" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherForeignCountriesMember" xlink:label="loc_lly_OtherForeignCountriesMember_5B14F49EAAB7F5865F88FE8D9B30793F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_6219EA512EA8412BBA73FE8D9B30AB02" xlink:to="loc_lly_OtherForeignCountriesMember_5B14F49EAAB7F5865F88FE8D9B30793F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_09CD119DBF2F53CE3BFFFE8D9B30F2EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_107986D68E0D763C5D55FE8D9B304006" xlink:to="loc_us-gaap_ProductOrServiceAxis_09CD119DBF2F53CE3BFFFE8D9B30F2EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_09CD119DBF2F53CE3BFFFE8D9B30F2EA" xlink:to="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EndocrinologyMember" xlink:label="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:to="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumalogMember" xlink:label="loc_lly_HumalogMember_5BF7A0B3C475764C3E9EFE8D9B31EC73" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_HumalogMember_5BF7A0B3C475764C3E9EFE8D9B31EC73" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_TrulicityMemberMember" xlink:label="loc_lly_TrulicityMemberMember_4F7108EAF0430FDFABDBFE8D9B31531F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_TrulicityMemberMember_4F7108EAF0430FDFABDBFE8D9B31531F" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumulinMember" xlink:label="loc_lly_HumulinMember_9131922E649D7065A9EDFE8D9B31CDF1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_HumulinMember_9131922E649D7065A9EDFE8D9B31CDF1" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ForteoMember" xlink:label="loc_lly_ForteoMember_02EAA40474C3D88DDB55FE8D9B314E6A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_ForteoMember_02EAA40474C3D88DDB55FE8D9B314E6A" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_BasaglarMember" xlink:label="loc_lly_BasaglarMember_47243DE23CB3697D03BBFE8D9B31BCA1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_BasaglarMember_47243DE23CB3697D03BBFE8D9B31BCA1" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_JardianceBIMember" xlink:label="loc_lly_JardianceBIMember_C5F91AE787F6977FEADEFE8D9B3192DF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_JardianceBIMember_C5F91AE787F6977FEADEFE8D9B3192DF" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_TrajentaBIMember" xlink:label="loc_lly_TrajentaBIMember_18DCD31BDCD5300AAF41FE8D9B311121" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_TrajentaBIMember_18DCD31BDCD5300AAF41FE8D9B311121" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherEndocrinologyMember" xlink:label="loc_lly_OtherEndocrinologyMember_F9FDF09150F8238A4FDDFE8D9B31B6C0" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_EndocrinologyMember_973ABC94AABBFB1B81A2FE8D9B30BC97" xlink:to="loc_lly_OtherEndocrinologyMember_F9FDF09150F8238A4FDDFE8D9B31B6C0" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OncologyMember" xlink:label="loc_lly_OncologyMember_0C8618C54DFAA270971CFE8D9B316D74" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:to="loc_lly_OncologyMember_0C8618C54DFAA270971CFE8D9B316D74" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AlimtaMember" xlink:label="loc_lly_AlimtaMember_001E56E46F5F5344DD0CFE8D9B3126CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_OncologyMember_0C8618C54DFAA270971CFE8D9B316D74" xlink:to="loc_lly_AlimtaMember_001E56E46F5F5344DD0CFE8D9B3126CC" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CyramzaMember" xlink:label="loc_lly_CyramzaMember_7D2D3C66C80F512F7879FE8D9B313E51" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_OncologyMember_0C8618C54DFAA270971CFE8D9B316D74" xlink:to="loc_lly_CyramzaMember_7D2D3C66C80F512F7879FE8D9B313E51" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ErbituxMember" xlink:label="loc_lly_ErbituxMember_0CAAF9BFBAF0878BF320FE8D9B3142D3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_OncologyMember_0C8618C54DFAA270971CFE8D9B316D74" xlink:to="loc_lly_ErbituxMember_0CAAF9BFBAF0878BF320FE8D9B3142D3" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherOncologyMember" xlink:label="loc_lly_OtherOncologyMember_58EB56A91C2709B25F00FE8D9B317B52" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_OncologyMember_0C8618C54DFAA270971CFE8D9B316D74" xlink:to="loc_lly_OtherOncologyMember_58EB56A91C2709B25F00FE8D9B317B52" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CardiovascularMember" xlink:label="loc_lly_CardiovascularMember_CB12FDE8A539102B8F12FE8D9B31E883" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:to="loc_lly_CardiovascularMember_CB12FDE8A539102B8F12FE8D9B31E883" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CialisMember" xlink:label="loc_lly_CialisMember_972D8815EB60B1E49AAAFE8D9B31EFBF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_CardiovascularMember_CB12FDE8A539102B8F12FE8D9B31E883" xlink:to="loc_lly_CialisMember_972D8815EB60B1E49AAAFE8D9B31EFBF" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_EffientMember" xlink:label="loc_lly_EffientMember_CAD6D767565AF248C6DDFE8D9B313FBD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_CardiovascularMember_CB12FDE8A539102B8F12FE8D9B31E883" xlink:to="loc_lly_EffientMember_CAD6D767565AF248C6DDFE8D9B313FBD" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherCardiovascularMember" xlink:label="loc_lly_OtherCardiovascularMember_0647B5D865D4E8AD50F3FE8D9B3130D4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_CardiovascularMember_CB12FDE8A539102B8F12FE8D9B31E883" xlink:to="loc_lly_OtherCardiovascularMember_0647B5D865D4E8AD50F3FE8D9B3130D4" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_NeuroscienceMember" xlink:label="loc_lly_NeuroscienceMember_9A935498F7ED2BA30B02FE8D9B328F7B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:to="loc_lly_NeuroscienceMember_9A935498F7ED2BA30B02FE8D9B328F7B" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_CymbaltaMember" xlink:label="loc_lly_CymbaltaMember_8A14A10C700B1FCE5D2BFE8D9B326932" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_NeuroscienceMember_9A935498F7ED2BA30B02FE8D9B328F7B" xlink:to="loc_lly_CymbaltaMember_8A14A10C700B1FCE5D2BFE8D9B326932" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_StratteraMember" xlink:label="loc_lly_StratteraMember_D9091F4AE1DF108E9C3AFE8D9B3271D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_NeuroscienceMember_9A935498F7ED2BA30B02FE8D9B328F7B" xlink:to="loc_lly_StratteraMember_D9091F4AE1DF108E9C3AFE8D9B3271D1" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ZyprexaMember" xlink:label="loc_lly_ZyprexaMember_AC1A0BBE1BD983291860FE8D9B326302" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_NeuroscienceMember_9A935498F7ED2BA30B02FE8D9B328F7B" xlink:to="loc_lly_ZyprexaMember_AC1A0BBE1BD983291860FE8D9B326302" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherNeuroscienceMember" xlink:label="loc_lly_OtherNeuroscienceMember_8A9FC84039C59CB5D232FE8D9B32BCAE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_NeuroscienceMember_9A935498F7ED2BA30B02FE8D9B328F7B" xlink:to="loc_lly_OtherNeuroscienceMember_8A9FC84039C59CB5D232FE8D9B32BCAE" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_ImmunologyMember" xlink:label="loc_lly_ImmunologyMember_6F7ECA932D10F36D13D4FE8D9B32B8D0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:to="loc_lly_ImmunologyMember_6F7ECA932D10F36D13D4FE8D9B32B8D0" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_TaltzMember" xlink:label="loc_lly_TaltzMember_9C9E97A3588D9F7F1440FE8D9B323AD1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_ImmunologyMember_6F7ECA932D10F36D13D4FE8D9B32B8D0" xlink:to="loc_lly_TaltzMember_9C9E97A3588D9F7F1440FE8D9B323AD1" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherImmunologyMember" xlink:label="loc_lly_OtherImmunologyMember_2A558965E66EF909AB70FE8D9B3245EE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lly_ImmunologyMember_6F7ECA932D10F36D13D4FE8D9B32B8D0" xlink:to="loc_lly_OtherImmunologyMember_2A558965E66EF909AB70FE8D9B3245EE" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_OtherPharmaceuticalsMember" xlink:label="loc_lly_OtherPharmaceuticalsMember_9134C8C0FC8A0310A1E9FE8D9B326BB2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_CD4C3A181D0D79B0D9FDFE8D9B30DB34" xlink:to="loc_lly_OtherPharmaceuticalsMember_9134C8C0FC8A0310A1E9FE8D9B326BB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_304F76B97FD315728DE2FE8D9B32A523" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_107986D68E0D763C5D55FE8D9B304006" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_304F76B97FD315728DE2FE8D9B32A523" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8B26E8721F1AA7B147A6FE8D9B327BDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_304F76B97FD315728DE2FE8D9B32A523" xlink:to="loc_us-gaap_SegmentDomain_8B26E8721F1AA7B147A6FE8D9B327BDA" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumanPharmaceuticalProductsMember" xlink:label="loc_lly_HumanPharmaceuticalProductsMember_02ADCA3D50D8C6EB2793FE8D9B3230CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8B26E8721F1AA7B147A6FE8D9B327BDA" xlink:to="loc_lly_HumanPharmaceuticalProductsMember_02ADCA3D50D8C6EB2793FE8D9B3230CF" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AnimalHealthProductsMember" xlink:label="loc_lly_AnimalHealthProductsMember_97D1D11BC22AC2F6B0E2FE8D9B32154F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8B26E8721F1AA7B147A6FE8D9B327BDA" xlink:to="loc_lly_AnimalHealthProductsMember_97D1D11BC22AC2F6B0E2FE8D9B32154F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6736526917644B348465FE8D9B320BE2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_107986D68E0D763C5D55FE8D9B304006" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6736526917644B348465FE8D9B320BE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_FD4C641118154D818D17FE8D9B3278B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6736526917644B348465FE8D9B320BE2" xlink:to="loc_us-gaap_Revenues_FD4C641118154D818D17FE8D9B3278B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaap_OtherSalesRevenueNet_FD00066402ADC7E33555FE8D9B32AD47" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6736526917644B348465FE8D9B320BE2" xlink:to="loc_us-gaap_OtherSalesRevenueNet_FD00066402ADC7E33555FE8D9B32AD47" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/SegmentInformationSegmentProfitDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_836F322DCA40ED9B1532F099B02625CA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_C60AE05B4D57B1A33680F099B026CE24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_836F322DCA40ED9B1532F099B02625CA" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_C60AE05B4D57B1A33680F099B026CE24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_CFCFCA2548AED0F3F6F3F099B0262449" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_C60AE05B4D57B1A33680F099B026CE24" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_CFCFCA2548AED0F3F6F3F099B0262449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_2CD011E604DC5EE1DF33F099B0268087" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_CFCFCA2548AED0F3F6F3F099B0262449" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_2CD011E604DC5EE1DF33F099B0268087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAdjustmentToInventoryMember" xlink:label="loc_us-gaap_FairValueAdjustmentToInventoryMember_275DA540494109829888F099B0263EF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_2CD011E604DC5EE1DF33F099B0268087" xlink:to="loc_us-gaap_FairValueAdjustmentToInventoryMember_275DA540494109829888F099B0263EF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_3213A2288F77138D1042F099B02676B7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_C60AE05B4D57B1A33680F099B026CE24" xlink:to="loc_us-gaap_ConsolidationItemsAxis_3213A2288F77138D1042F099B02676B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_CEDED9A7AD57B55F8B3DF099B026AC5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsAxis_3213A2288F77138D1042F099B02676B7" xlink:to="loc_us-gaap_ConsolidationItemsDomain_CEDED9A7AD57B55F8B3DF099B026AC5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_F5793CDAAAE29D275759F099B0261657" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_CEDED9A7AD57B55F8B3DF099B026AC5E" xlink:to="loc_us-gaap_OperatingSegmentsMember_F5793CDAAAE29D275759F099B0261657" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_F5CC11F2327B237BADA7F099B0264D50" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_CEDED9A7AD57B55F8B3DF099B026AC5E" xlink:to="loc_us-gaap_CorporateNonSegmentMember_F5CC11F2327B237BADA7F099B0264D50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_23A6335B2B20273600EDF099B026D831" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_C60AE05B4D57B1A33680F099B026CE24" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_23A6335B2B20273600EDF099B026D831" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_0368AF714F65C83FAF93F099B0266371" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_23A6335B2B20273600EDF099B026D831" xlink:to="loc_us-gaap_SegmentDomain_0368AF714F65C83FAF93F099B0266371" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_HumanPharmaceuticalProductsMember" xlink:label="loc_lly_HumanPharmaceuticalProductsMember_629D82CD335D4F3F3130F099B02647C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0368AF714F65C83FAF93F099B0266371" xlink:to="loc_lly_HumanPharmaceuticalProductsMember_629D82CD335D4F3F3130F099B02647C1" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AnimalHealthMember" xlink:label="loc_lly_AnimalHealthMember_122870547919392610B8F099B026912E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0368AF714F65C83FAF93F099B0266371" xlink:to="loc_lly_AnimalHealthMember_122870547919392610B8F099B026912E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_C60AE05B4D57B1A33680F099B026CE24" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_225B21B15BC232A692C2F099B027903E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_225B21B15BC232A692C2F099B027903E" xlink:type="arc" />
    <link:loc xlink:href="lly-20180331.xsd#lly_AcquiredInProcessResearchAndDevelopment" xlink:label="loc_lly_AcquiredInProcessResearchAndDevelopment_C4A1A9ACF5714CD4705CF099B027B449" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:to="loc_lly_AcquiredInProcessResearchAndDevelopment_C4A1A9ACF5714CD4705CF099B027B449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_D02286E619B74F3382C1F099B028EEF2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_D02286E619B74F3382C1F099B028EEF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_9A8E8CCEC2007DE61A19F099B02848CE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_9A8E8CCEC2007DE61A19F099B02848CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_9071B254E1B73E3DEECDF099B02DD32A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_03656CDD4569D2FA7DC2F099B027AC53" xlink:to="loc_us-gaap_CostOfGoodsSold_9071B254E1B73E3DEECDF099B02DD32A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_53B2C245FA0BF99E5292CF14DB19ADDC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_312A55F2F4C081024241CF14DB197DEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_53B2C245FA0BF99E5292CF14DB19ADDC" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_312A55F2F4C081024241CF14DB197DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_0FDEA18BB428E9EEBC68CF14DB19F214" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_53B2C245FA0BF99E5292CF14DB19ADDC" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_0FDEA18BB428E9EEBC68CF14DB19F214" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_645229765EE757C2867B28DA902F837D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4AF8197918915478B164D47B5184FCA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_645229765EE757C2867B28DA902F837D" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4AF8197918915478B164D47B5184FCA0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.lilly.com/role/ShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_3856A7554D47237C60020709CEE62EED" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9CCEB0491957A94C96F60709CEE6B46E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3856A7554D47237C60020709CEE62EED" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9CCEB0491957A94C96F60709CEE6B46E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_42E4B286676610D3BF120709CEE62869" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3856A7554D47237C60020709CEE62EED" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_42E4B286676610D3BF120709CEE62869" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_CD14F2829AF5BF0ACFEA0709CEE6C96A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3856A7554D47237C60020709CEE62EED" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_CD14F2829AF5BF0ACFEA0709CEE6C96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E550F1C608AE7BABC8670709CEE6AEA8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3856A7554D47237C60020709CEE62EED" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E550F1C608AE7BABC8670709CEE6AEA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_917CDFDA6C1C1C0AFAC30709CEE64EFD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3856A7554D47237C60020709CEE62EED" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_917CDFDA6C1C1C0AFAC30709CEE64EFD" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
